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Abstract 
 
Pulmonary disease associated with non-tuberculous mycobacteria (NTM) is a poorly understood 
and difficult to treat condition. It is an increasingly common problem in a subset of older 
individuals, with NTM lung disease now reported more frequently than tuberculosis in Australia. 
Environmental exposure appears to be the primary route for pulmonary NTM infection, but specific 
risk factors remain poorly determined. A large subset of patients with pulmonary NTM disease 
appears to be immunocompetent, but the existence of an as yet unidentified deficiency in these 
patients’ immune response to NTM infection may influence their risk of infection.  
 
This thesis begins with a review of the evidence that pathogenic species of NTM have been isolated 
from drinking water distribution systems, soil and house dust, so exposure may be very common. A 
defect in immune response appears critical to the development of disease. Ways by which genetic 
make-up may predispose some individuals to pulmonary NTM disease were addressed. This 
involved investigations of polymorphic alleles across IL10 and a group of three novel genes P2X4R, 
P2X7R and CAMKK2.    
 
DNA was obtained from 124 patients with pulmonary NTM disease attending Greenslopes Private 
Hospital, QLD, Australia and Prince Charles Hospital, QLD, Australia between 2005 and 2014. 
DNA from an additional 229 healthy control donors recruited from Western Australia (Temple et al., 
2003)(Temple et al., 2003)(Temple et al., 2003) (Temple et al., 2003) was provided by the Institute 
for Respiratory Health, Western Australia.  
 
A strong association between pulmonary NTM disease and a polymorphism within IL10 
(rs1518111), and a haplotype spanning the three genes P2X4R, P2X7R and CAMKK2 were 
identified. These results implicate these genes (or other genes in linkage disequilibrium with them) 
and their products as factors contributing to infection and disease. This information may prove 
critical in developing new strategies and therapies for patients with NTM disease and may provide 
critical insights into other mycobacterial diseases such as leprosy and tuberculosis.  
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1) Introduction and Literature Review 
 
 
1.1) Pathology of Pulmonary NTM disease 
Pulmonary disease associated with non-tuberculous mycobacteria (NTM) is an increasingly 
common problem in a subset of older individuals. Although frequency of reported NTM lung 
disease varies greatly around the world, it is now reported more frequently than tuberculosis in 
Queensland, Australia where it is a reportable condition (21.8 pulmonary NTM cases per 100, 000 
compared to 3.8 Tuberculosis cases per 100, 000 in 2015) (Queensland Health, 2015a, Queensland 
Health, 2015b). Pulmonary NTM disease is thought to be primarily transmitted from the inhalation 
of pathogenic NTM from the surrounding environment. A full review of the literature analysing 
NTM disease epidemiology was published as a component of this project (See Chapter 3). 
Pulmonary NTM disease is develops slowly and is difficult to eradicate, with patients experiencing 
bouts of active infection and periods of remission. Infections by different species have different 
expected outcomes. When the appropriate antimicrobial regimens are administered, the cure rate for 
M. kansasii is reported at around 90% (similar to M. tuberculosis infection) while M. avium is cured 
in 30-85% of patients. For patients with pulmonary M. abscessus infection complete recovery can 
be achieved but is unpredictable (Marušić and Janković, 2012). 
The main mechanism of infection appears to be inhalation of aerosolised NTM. As intracellular 
pathogens, the NTM invade and replicate within host lung epithelia and alveolar phagocytes. In a 
majority of cases, it is thought that the innate immune system prevents the bacteria from exploiting 
local cells in this way. However, in a small subset of individuals, predominantly thin elderly 
women, an unknown susceptibility allows the development of fibronodular disease (Chan and 
Iseman, 2010, Thomson, 2010). 
 
1.2) How are people exposed to NTM? 
When aiming to identify major risk factors leading affecting an individual’s chances of pulmonary 
NTM disease, the first consideration is exposure and transmission of the pathogen. A review of the 
literature assessing confirmed cases of transmission of pathogenic NTM causing disease was written 
and published, exposing the knowledge gaps in research (See Chapter 3). 
This review concludes that while aerosolisation of water appears to be the most reported and 
confirmed transmission route of pathogenic NTM, there is not enough data to say with certainty that 
3 
 
it is the primary method of transmission. However, it does appear that the majority of pathogenic 
NTM are not transmitted person-to-person, but exclusively from exposure to environmental sources 
such as water, soil and dust. As exposure to pathogenic NTM appears to be widespread, it is likely 
that risk of pulmonary NTM infection and disease is largely determined by differences in host 
susceptibility to these bacteria.  
 
1.3) Could a host genetic polymorphism influence susceptibility to NTM? 
Genetic polymorphism could help to explain the selective nature of pulmonary NTM infections in 
individuals with apparently healthy immune systems. Previous work from our team identified 
alleles of TNFA, IL12B and (most clearly) IL10 affecting pulmonary NTM disease (Affandi et al., 
2013). The study also found several alleles of genes encoding mediators of T-cell activation and 
inflammation that did not associate with NTM disease (See Table1.1), so here we have focussed on 
genes that may have a fundamental role in inflammation. 
The most promising gene was IL10, as the (A) allele of rs1800896 has been significantly associated 
with pulmonary NTM disease and perturbations of the Th1/Th2 balance (Affandi et al., 2013). 
Previous studies have also  observed high production of IL-10 in blood mononuclear cells from 
NTM patients (Lim et al., 2010). A more complete review of IL10s perceived relevance to 
pulmonary NTM disease is included as part of a short communication (Chapter 4).  Affandi et al. 
also identified SNPs in IL28B and TNFA associated with pulmonary NTM disease, but were not 
investigated further in my project. SNPs affecting genes including BAT1, IL1A, IL2, IL18, CCL2, 
CD14, IL-12B and SLC11A1 were investigated but did not appear associated with disease (Affandi 
et al., 2013). These genes were not investigated further. Although the Affandi review produced few 
strong leads, it highlights the perceived mechanisms capable of affecting susceptibility to 
pulmonary NTM disease (pattern-recognition molecules, surfactant proteins, signalling pathways, 
pro-inflammatory cytokines and the anti-inflammatory response), identifies SNP likely to affect 
these processes, and conveys the need for further effective genetic studies (Affandi et al., 2010).  
Genes investigated in this thesis are described here.  
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Table 1: NTM disease was significantly associated with alleles of TNFA-1031 and IL10-1082 (from Affandi, 2013). 
Gene Alias/SNP (wt/var) 
(rs no.)                   
Taqman Cat no. 
Geno-
type 
Controls 
(n=188)  
NTM 
Cases 
(n=79)  
ORa 95% 
CIb 
Pc   Gene Alias/SNP   
(rs no.)        
Taqman Cat no. 
Geno-
type 
Controls 
(n=188)a  
NTM 
Cases 
(n=79)a  
ORa 95% 
CIb 
Pc 
TNFA-308
d
 GG 105 58     CCL2-2518 
d
 AA 110 38    
rs1800629 GA 52 21 0.73 0.4-1.3 0.31  rs1024611 AG 63 32 1.47 0.8-2.6 0.18 
C_7514879_10 AA 4 0 1.00
f
 0.4-0.8 Na  C_2590362_10 GG 15 9 1.74 0.7-4.3 0.23 
TNFA-1031 d CC 113 58     VDR FokI
f
 CC 67 28    
rs1799964 CT 62 16 0.50 0.3-0.9 0.03  rs10735810 CT 89 38 1.02 0.6-1.8 0.94 
C_7514871_10 TT 9 4 0.86 0.2-2.9 0.82  C_12060045_20 TT 28 13 1.10 0.5-2.5 0.80 
BAT1(intron 10 
e
 – 122 66     CD14 C(-159)Td CC 45 16    
rs9281523 -C 39 13 0.32 0.3-1.2 0.17  rs2569190 CT 92 45 1.37 0.7-2.7 0.35 
 CC 3 0 0.54 0.4-0.7 0  C_16043997_10 TT 42 18 1.20 0.5-2.7 0.65 
IL1A+4845
g
 CC 86 37     IL10-1082 d AA 38 29    
rs17561 CA 94 34 0.84 0.5-1.5 0.54  rs1800896 GA 109 33 0.40 0.2-0.7 0.004 
C_9546471_10 AA 7 8 2.70 0.9-7.9 0.07  C_1747360_10 GG 41 17 0.54 0.3-1.1 0.11 
IL2-330 d TT 92 36     IL12B 3’UTRh AA 136 53    
rs2069762 TG 77 39 1.29 0.8-2.2 0.35  rs3212227 AC 43 22 1.31 0.7-2.4 0.38 
C_15859930_10 GG 19 4 0.54 0.2-1.7 0.29  C_2084293_10 CC 9 4 1.14 0.3-3.8 0.83 
IL4-589
d
 CC 144 60     SLC11A1 
D543N
g
 
GG 182 74    
rs2243250 CT 37 16 1.04 0.5-2.0 0.91  rs17235409 AG 6 4 1.64 0.4-5.9 0.45 
C_16176216_10 TT 5 3 1.44 0.3-6.2 0.63  C_25635296_10 AA 0 1 1.00 0.3-0.5 0 
IL18-137
d
 GG 88 47     IL28B SNP1
d
 TT 144 50    
rs187238 GC 65 25 0.72 0.4-1.3 0.27  rs8099917 TG 41 25 1.76 0.9-3.2 0.06 
C_2408543_10 CC 17 7 0.77 0.3-1.9 0.59  C_11710096_10 GG 3 4 3.84 0.8-17 0.08 
IL18-607
d
 TT 62 25     IL28B SNP2
d
 CC 106 43    
rs1946518 TG 78 39 1.20 0.4-2.3 0.48  rs12979860 CT 70 36 1.27 0.7-2.2 0.39 
C_2898460_10 GG 29 15 1.28 0.6-2.8 0.53   TT 10 0 1.00 0.3-0.6 0 
rs = reference SNP number. 
a
 OR = Odds ratio 95%, 
b
 CI = 95% Confidence interval, 
c
 Univariate P value calculated by logistic regression modelling (Significant P values ≤ 
0.05), 
d
 Promoter region, 
e
 Intron, f Exon, 
d
 Nonsynonymous, 
h
 3` Untranslated region.
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1.3.1)  IL-10 
IL10 is a target of interest for further genetic analysis based on previous work within our group 
(Affandi et al., 2013). The IL10 SNP associated with NTM susceptibility associated with lower 
levels of IL-10, but we and others demonstrated higher than normal IL-10 production by 
mononuclear cells when cultured with mycobacterial antigen (Lim et al., 2010, Turner et al., 1997). 
Additional IL10 SNPs and their potential associations with NTM disease are a promising area of 
investigation (See Chapter 4). 
 
The three genes P2X7R, P2X4R, and CAMKK2 are located adjacent to one another on chromosome 
12, and as such are in linkage disequilibrium (see Figure 1). They represent a major new initiative 
in genetic studies of NTM as they have not been considered previously. 
 
1.3.2) P2X7R 
The P2X7R gene encodes the P2X7R protein, an ATP-gated ion channel which plays an important 
role in the innate immune response. When bound by its ligand, extracellular ATP, P2X7R enables 
the intracellular killing of phagocytosed bacteria (ie: NTM) in the presence of local inflammatory 
stress. 
A loss of function polymorphism in the P2X7R gene (rs3751143) increases susceptibility to 
extrapulmonary tuberculosis but this occurrence has not been investigated in patients with 
pulmonary NTM disease (Fernando et al., 2007). This SNP is one of several within P2X7R being 
investigated in this project. Any one of these polymorphisms may alter function in the P2X7R 
channel, potentially allowing the evasion of a macrophage phagocytosis response by infectious 
agents.  
 
1.3.3) P2X4R 
P2X4R encodes the P2RX4 protein, a purinoreceptor activated by ATP allowing the transport of 
calcium ions across a membrane. It is generally co-expressed with P2X7R in intracellular lysosomal 
compartments of macrophages and microglia, but can be rapidly trafficked to the surface membrane 
via the process of endolysosomal secretion (Stokes and Surprenant, 2009).  
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P2X4R appears to be involved in the process of phagocytosis, lysosomal destruction and removal of 
pathogens taken up by macrophages, specifically post-fusion phase exocytosis (Miklavc et al., 
2011). Polymorphisms in the P2X4R gene may allow exploitation of this system by nontuberculous 
mycobacterium, which can persist in macrophage phagosomes via inhibition of lysosome binding. 
 
1.3.4) CAMKK2 
CaMKK2 is a common calcium ion activated protein kinase involved in the function of many 
different pathways, potentially including lymphocyte activation. It may act downstream of P2RX4 
in the process of exocytosis in macrophages that have taken up NTM. P2X4R allows calcium ions 
to traverse membranes activating CaMKK2 pathways. This function may be affected by loss of 
function mutations leading to an increased susceptibility to NTM. 
CaMKK2 is selectively expressed in monocytes/macrophage (Racioppi et al., 2012). In knockout 
mice, CaMKK2-null macrophages displayed a deficiency to spread, phagocytose bacteria, and 
synthesize cytokines in response to the Toll-like receptor 4 (TLR4) agonist lipopolysaccharide 
(LPS) (Racioppi et al., 2012). Loss of CaMKK2 action uncouples the TLR4 cascade from activation 
of PTK2B, thereby failing to properly activate the inflammatory response. The general macrophage 
weakening reported in the areas of migration, phagocytosis and cytokine production in the 
CAMKK2 KO-mice demonstrates the potential effect of deleterious mutations on NTM disease 
susceptibility.
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Figure 1: Linkage disequilibrium plots for SNPS in P2X7R, P2X4R and CAMKK2 found in the Caucasian (CEU) population. Solid red blocks indicate 
instances where two SNPs are invariably inherited together. The likelihood decreases with pink shading; white blocks show SNPs that are rarely inherited 
together. The blue blocks represent combinations where co-inheritance has not yet been investigated (Goullee et al., 2016). As IL10 is located on a different 
chromosome (chromosome 1) it has not been included in linkage analysis. 
 
P2X7 P2X4 CAMKK2 
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1.3.5) TLR2 
TLR2 was investigated. SNP within TLR2 (rs4696480 and rs5743706) have been associated with an 
increased risk of pneumonia and gram-negative sepsis (Affandi et al., 2010, Lorenz et al., 2002, 
Sutherland et al., 2005). Immune processes involving TLR2 have been associated with pulmonary 
disease, raising the possibility of TLR2 polymorphism affecting pulmonary NTM disease. This is 
the case for pulmonary surfactant protein B polymorphism associating with risk of pneumonia and 
Myeloid differentiation factor 88 (signalling downstream of TLR2) polymorphism associating with 
decreased susceptibility to pneumococcal disease (Beutler, 2002, Griese et al., 2008).  However 
none of the SNP investigated within this gene (rs3804099, rs3804100 and rs5743704) associated 
significantly with pulmonary NTM disease in our cohort.  
 
1.3.6) IL4 
IL4 was also investigated. IL4 produces IL-4, a Th2 differentiating factor for naïve T-cells and 
suppressor of Th1 responses (Brown and Hural, 1997, Martinez et al., 1990). The four SNP 
investigated within IL4 in our study (rs2243250, rs2070874, rs2243282 and rs2227284) have 
previously been associated with other conditions including rheumatoid arthritis severity, and 
increased odds of asthma in Caucasians (Balsa et al., 2009, Baye et al., 2011). However, none 
displayed significant associations with pulmonary NTM disease. 
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Chapter 2: 
Hypothesis development and aims of study  
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2) Hypothesis development and Aims of Study 
 
Pulmonary NTM disease appears to be contracted primarily from environmental sources, with 
human to human transmission being a relatively rare transmission route. Unlike tuberculosis, most 
pulmonary NTM infections have no routes of transmission identified. NTM are opportunistic 
pathogens, but many patients have no overt immunodeficiency, suggesting the possibility of a more 
subtle or specific predisposing factor. What factors determine risk of infection and disease? 
2.1) Hypotheses 
This thesis addresses two hypotheses: 
1) The primary route of pathogenic NTM transmission is via contaminated water. 
And, 
2) Frequencies of polymorphic SNP alleles previously implicated in tuberculosis and other 
infectious or pulmonary diseases differ in patients of pulmonary NTM disease.  
 
2.2) Specific Aims 
1) To determine how a majority of pathogenic NTM are transmitted to patients, assuming all are 
equally susceptible to infection. A comprehensive review of confirmed cases of transmission of 
pathogenic NTM from known sources resulting in infection and disease was constructed to 
determine the primary route of transmission (Chapter 3).  
 
And, 
 
2) Assuming exposure is common across the population, to determine if there are immunogenetic 
differences between apparently immunocompetent patients with pulmonary NTM disease and 
healthy controls? Genetic association studies were performed on SNP within the candidate genes 
IL10, P2X4R, P2X7R, CAMKK2, IL4 and TLR2 in patients with pulmonary NTM disease and 
healthy controls (Chapters 4 and 5). Candidate genes were chosen based on the reviewed literature 
(Chapters 1, 4 and 5).   
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Chapter 3: 
Review of pathogenic NTM transmission 
from environmental sources 
 
 
This section of work consists of an extensive published review of the literature regarding 
transmission of pathogenic NTM from environmental sources. This paper is included as both a 
research component and major section of the literature review for this thesis. 
 
 
Full citation: Halstrom, S., Price, P. and Thomson, R., 2015. Review: environmental mycobacteria 
as a cause of human infection. International journal of Mycobacteriology, 4(2), 81-91. PMID: 
26972876. 
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Abstract 
 
Pulmonary infections with nontuberculous mycobacteria (NTM) are recognised as a problem in 
immunodeficient individuals and are increasingly common in older people with no known immune 
defects. NTM are found in soil and water, but factors influencing transmission from the 
environment to humans are mostly unknown. Studies of the epidemiology of NTM disease have 
matched some clinical isolates of NTM with isolates from the patient’s local environment.  
Definitive matching requires strain level differentiation based on molecular analyses including 
partial sequencing, PCR-restriction fragment length polymorphism (RFLP) analysis, random 
amplified polymorphic DNA (RAPD) PCR, repetitive element (rep-) PCR and  pulsed field gel 
electrophoresis (PFGE) of large restriction fragments. These approaches have identified hospital 
and residential showers and faucets, hot-tubs and garden soil as sources of transmissible pathogenic 
NTM. However gaps exist in the literature, with many clinical isolates remaining unidentified 
within environments tested and few studies investigating NTM transmission in developing 
countries. To understand the environmental reservoirs and transmission routes of pathogenic NTM, 
more studies, investigating different environments, countries and climates are required. 
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3.1) Factors affecting the acquisition of pulmonary NTM 
Pulmonary infections with nontuberculous mycobacteria (NTM) are an increasing problem in many 
countries. Symptoms include chronic cough, haemoptysis, weight loss, fever and progressive 
fatigue - similar to Mycobacterium tuberculosis pulmonary infection.  Diagnoses are made with 
chest radiography, detection of acid fast bacilli in sputum and cultures from sputum and 
bronchoalveolar lavage fluids (Griffith et al., 2007). The increasing prevalence may reflect an aging 
population, as symptomatic infections are most common in post-menopausal women and older men. 
NTM infections can also manifest as lymphadenitis, disseminated disease, or skin, tissue or bone 
disease. Disseminated NTM disease is associated with genetic defects in the Th1 pathway - 
lymphadenitis is often seen in patients with advanced HIV disease, whilst skin, tissue and bone 
infections usually follow trauma at the site of infection. Pulmonary NTM infections in older 
individuals with no recognized immune defects carry a high morbidity and economic cost, as 
current treatments have multiple side effects and an intention-to-treat cure rate of <50%. Even in 
apparent cures, the relapse rate is 50% at 3 years (Thomson and Yew, 2009). Thus it is important to 
determine the source and mode of transmission of pathogenic strains in the environment for 
advancement of prophylactic measures, as subtle immune deficiencies are rarely evident prior to the 
diagnosis of NTM disease. 
 
Pathogenic NTM comprise many species and strains found in water and soil. For a better 
understanding of NTM disease risk and to develop prophylactic measures, clinical and 
environmental NTM isolates need to be matched. This will identify critical environmental 
reservoirs and routes of transmission. Here we review studies where clinical and environmental 
strains of mycobacteria were matched and discuss limitations to the methodology employed. 
 
3.2) NTM are common in many environments 
NTM have been isolated from drinking water pipelines (Thomson et al., 2013b, Torvinen et al., 
2004), water tanks (Tuffley and Holbeche, 1980), hot tubs (Mangione et al., 2001), residential 
faucets (Slosarek et al., 1993, Thomson et al., 2013a), hospital faucets and ice machines (Cooksey 
et al., 2008, Galassi et al., 2003), diagnostic laboratories (Chang et al., 2002), bottled and municipal 
water, commercial and hospital ice (Covert et al., 1999), potting soil (De Groote et al., 2006), house 
dust (Dawson, 1971, Torvinen et al., 2010), water damaged building materials (Torvinen et al., 
2006), showerheads (Falkinham III et al., 2008), shower aerosols (Thomson et al., 2013a), hot-tub 
aerosols (Mangione et al., 2001), coniferous forest soils (Iivanainen et al., 1997), brook waters 
(Iivanainen et al., 1993), cigarettes (Eaton et al., 1995), livestock (Leite et al., 2003), coastal mosses 
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(Schröder et al., 1992) and seawater (Gruft et al., 1979). Reports span multiple countries (including 
the USA, Australia, the UK, France, the Netherlands, Denmark, Czechoslovakia, Italy, Finland, 
Germany, Madagascar, Tanzania, Taiwan, Japan and Korea) and climates. While many isolates were 
not directly associated with human disease, these reports show that NTM reside in a variety of 
natural and artificial environments. 
 
3.3) Environments of interest are defined 
Inhalation of aerosols appears to be the primary transmission route of NTM causing pulmonary 
disease. This usually occurs in artificial water environments such as hot-tubs and showers, but may 
involve garden soil and house dust. Mycobacteria may aerosolise more readily than other bacteria 
as they have highly hydrophobic cell walls. NTM have been isolated from natural water 
environments in which aerosolisation increases NTM concentration in the air (Parker et al., 1983, 
Wendt et al., 1980). However these studies will not be discussed here as the aerosols were not 
linked to NTM disease. 
 
When aiming to identify NTM, the depth of identification should be considered. Species level is 
sufficient to determine presence or absence in an environment, but strain level identification is 
required when matching clinical and environmental isolates. For species level NTM identification, 
cheap lower resolution techniques include phenotypic and biochemical typing, RT-PCR, species 
specific DNA probe kits, HPLC of mycolic acids and sequencing of select genes (namely 16S, rpoB 
and/or hsp65). Serotyping (Tuffley and Holbeche, 1980) and phage typing (Engel et al., 1980) have 
been utilised, but are now less popular as more species of mycobacteria have been recognised. 
 
With low resolution techniques, environments of interest can be selected based on assessments of 
NTM presence. Demonstrations of transmission causing disease require higher resolution typing 
techniques such as RFLP, PFGE, or rep-PCR. Although commonly used for species identification, 
RT-PCR or gene sequencing provide strain level identification if optimised correctly (Table 2). 
These techniques are discussed further in section 4. When clinical and environmental isolates are 
matched at species level only, conclusions should be treated with caution. False positive matches 
may occur when different strains of the same NTM species are present in different environmental 
locations (Cooksey et al., 2008). 
 
Excessive exposure to NTM-containing aerosols can also result in hypersensitivity pneumonitis 
(HP) in people with no known immune deficiencies. This was documented in machine workers 
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following repeated inhalation of aerosolised contaminated metal removal fluids (Shelton et al., 
1999). However the most frequently reported cause of NTM HP is aerosolisation of contaminated 
hot-tub and swimming pool water, with multiple reports describing patients who developed NTM 
HP from these sources after frequent use (Embil et al., 1997, Glazer et al., 2007, Kahana et al., 
1997, Khoor et al., 2001, Marchetti et al., 2004, Rickman et al., 2002, Schwartzstein and Mark, 
2000). Whilst patients with NTM HP can present acutely and be significantly unwell, most cases 
resolve after exposure to the contaminated aerosols is discontinued. 
 
3.3.1) Water 
The most credible routes for pulmonary NTM infection involve inhalation of aerosols generated by 
hot-tubs and shower-heads. Indeed the global increase in NTM infections may reflect the use of 
showers rather than bathing (O'Brien et al., 2000). In a study of particular interest, Feazel used 
quantitative molecular techniques to show that the showerhead environment enriches biofilm-
forming organisms, including mycobacteria (Feazel et al., 2009). NTM organisms are common in 
treated water. Their innate resistance to chlorine and other disinfectants provides a growth 
advantage. The disinfectant resistance of NTM was demonstrated in Australia in a study of M. 
avium in hot-tubs (Lumb et al., 2004). Although the environmental bacterial load was kept at a low 
1 CFU/ml by chlorination, the same samples yielded NTM numbering between 4.5 x 103 and 4.3 x 
104 CFU/ml (Lumb et al., 2004).  
 
Although not affecting the lungs, NTM furunculosis has also been linked to salon foot-baths used 
by two patients in the USA (Gira et al., 2004). The infections are attributed to the use of 
contaminated foot baths after shaving of the legs had breached the skin barrier.  
   
NTM are also present in hospital environments. Earlier studies linking environmental and clinical 
NTM isolates found several NTM species were ubiquitous in hospital and residential taps and 
showers in the UK, the Netherlands and the Czech Republic (Engel et al., 1980, McSwiggan and 
Collins, 1974, Slosarek et al., 1993). Diagnosis of NTM disease can be confounded by false 
positive isolates due to contamination of diagnostic tests, as demonstrated in the USA (Goslee and 
Wolinsky, 1976) and Spain (Alvarez et al., 2008). NTM contaminating hospital materials can cause 
nosocomial outbreaks and pseudo-outbreaks (Panwalker and Fuhse, 1986, Wallace Jr et al., 1998). 
Prevention of nosocomial infections requires that medical instruments and patient wounds are not 
exposed to tap water (Griffith et al., 2007).  
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3.3.2)  Soil 
Studies of NTM in soil are less numerous than those of water, perhaps because soils are considered 
a less likely/common source of nosocomial infection and contain more overgrowing contaminants, 
complicating NTM isolation from culture. However NTM have been isolated from soil in multiple 
countries and climates, including Finland (Iivanainen et al., 1997), Japan (Ichiyama et al., 1988), 
the USA (Jones and Jenkins, 1965) and Uganda (Kankya et al., 2011). Some reports characterise 
isolates to the species level, but only one utilised molecular techniques to match clinical isolates 
with NTM isolated from garden soil (De Groote et al., 2006). Although the study matched 14 
clinical isolates with isolates from the patient’s own gardens, only three were true matches at the 
strain level. The authors isolated the organisms by generating aerosols with the soil samples, 
establishing that the isolates had potential to be aerosolised to a respirable particle size. 
 
3.3.3) House Dust 
Many NTM species have been isolated from house dust (Dawson, 1971). Although these studies 
used only species specific analyses for detection and characterisation, they establish house dust as a 
source of NTM (Torvinen et al., 2010). As dust particles are commonly suspended in the air, 
inhalation of mycobacteria associated with dust particles is a plausible source of pulmonary 
infections. An early study from Australia used serotyping (one of the first strain typing techniques 
described) to match house dust and patient isolates (Reznikov and Dawson, 1971). Approximately 
50% of these house dust strains were M. intracellulare matching the patient isolates. Further studies 
utilising more powerful techniques are needed to confirm these findings. 
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Table 2: Summary of popular molecular techniques for NTM strain characterisation. 
Name  Method of characterisation Papers describing the method in 
use 
Partial Sequencing Sequencing of particular genes and gene fragments (ie: 16S rDNA). 
Can directly compare SNPs of genomic DNA. 
(Harmsen et al., 2003), (Turenne et 
al., 2006) 
Repetitive sequence 
PCR (rep-PCR) 
PCR of genomic DNA with primers specific to multiple repetitive 
sequences.  
Separate amplicons via gel electrophoresis. 
Produces unique fingerprint patterns from multiple bands of varying 
intensity. 
(Thomson et al., 2014) 
Random 
amplification of 
polymorphic DNA 
(RAPD) 
PCR amplification, primers of random sequence utilised. 
Polyacrylamide gel electrophoresis performed on amplicons. 
Unique fingerprint generated. 
(Zhang et al., 1997)  
Restriction fragment 
length 
polymorphism 
(RFLP) 
Perform PCR with primer of interest. 
Digest amplicons with restriction enzymes and determination of 
fragment length via gel electrophoresis. 
Discriminates DNA strands based on the locations of restriction enzyme 
sites (as band patterns). 
(Lee et al., 2000) 
Pulsed field gel 
electrophoresis 
(PFGE) 
Amplify Genomic DNA by culture, digest into large restriction 
fragments and separate large restriction fragments via pulsed-field gel 
electrophoreses (ie: Electrophoresis where voltage periodically changes 
between three directions). 
Capable of accurate discrimination of sequences in long strands.  
(Tenover et al., 1995, Zelazny et al., 
2009) 
 
Amplified fragment 
length 
polymorphism 
(AFLP) 
Genomic DNA digested with restriction enzymes, adaptors ligated to 
restriction fragments, restriction fragments undergo PCR amplification, 
amplified fragments separated and visualised via polyacrylamide gel 
electrophoresis. 
Polymorphisms scored as present or absent from genome. 
(Pfaller et al., 2007) 
Multiplex PCR Multiple primer sets used in a single PCR reaction, targeting multiple 
genes.  
Amplicon sizes determined by gel electrophoresis. 
(Kim et al., 2011) 
High performance 
liquid 
chromatography 
(HPLC) 
Used to separate, identify, and quantify a mixture of components in 
liquid form.  
For NTM characterisation it is often used to fingerprint mycolic acid 
patterns. 
(Galassi et al., 2003) 
Identification kits Pre-packaged kits designed to identify certain NTM species. 
Directions and techniques vary between kits and manufacturers. 
(Thomson et al., 2014) 
 
 
3.4) Molecular methods allow NTM from patients and their environment to be matched  
Within environments identified by low resolution methods, environmental NTM have been 
compared using molecular techniques with isolates from patients. These techniques (Table 2) have 
been used as standalone procedures, and as part of a multistep fingerprinting process. Whilst strain 
differentiation within some individual species of NTM has been demonstrated using a single 
technique, this is not the case for all. Strain level differentiation across multiple NTM species 
requires a combination of differentiation techniques.  
 
Molecular techniques used for characterisation of NTM at the strain level include high performance 
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liquid chromatography (HPLC), repetitive PCR (rep-PCR), random amplified polymorphic DNA 
PCR (RAPD-PCR), pulsed-field gel electrophoresis (PFGE) of large restriction fragments, 
restriction fragment length polymorphism (RFLP), amplified fragment length polymorphism 
(AFLP), partial gene sequencing, and multiplex PCR (ie: using hsp65, 16S rDNA, ropB etc.). Table 
3 outlines studies in which these molecular techniques have been used to identify sources of clinical 
NTM isolates in the environment.   
 
Many PCR-based analyses (eg: 16s rDNA sequencing) do not distinguish mycobacterial taxa at the 
species level as the genes are conserved across the genus (Cloud et al., 2002). For example; M. 
kansasii/M. gastri and M. abscessus/M. chelonae share identical 16s rDNA sequences. Similar 
problems also affect NTM differentiation at the strain level. This can be achieved with the use of 
multiple analyses in tandem (Picardeau et al., 1997). In one study, comprehensive analyses of the 
discriminatory power of 16s rDNA, hsp65, and rpoB gene sequencing, hsp65 RFLP, rep-PCR, 
RAPD PCR, and PFGE of large restriction fragments were performed on isolates of M. 
mucogenicium and M. phocaicum. PFGE analysis displayed the greatest differentiation power 
showing each environmental isolate as genetically unique (Cooksey et al., 2008). However PFGE 
cannot differentiate all NTM strains isolated (MacCannell, 2013) and should be used in 
combination with other techniques to achieve greater discrimination. It is also labour and time 
intensive. 
 
Although not yet utilised in environmental and clinical isolate matching of NTM, it is becoming 
increasingly feasible to perform whole genome sequencing. Whilst offering definitive genomic 
differentiation of isolates, whole genome sequencing requires new stratagems in data management 
(MacCannell, 2013). When more sequences become available, targeted sequencing for accurate 
species identification will reduce costs and increase accessibility. Whole or targeted genome 
sequencing will likely replace PFGE as the gold standard for bacterial strain typing. 
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Table 3: Summary of studies utilising molecular methods to differentiate and match NTM isolates from clinical and environmental isolates. 
Country Clinical 
samples 
Environment 
investigated 
Environmental 
samples containing 
NTM: Number of 
environmental 
samples taken 
Matched clinical 
and 
environmental 
NTM isolates: 
total 
environmental 
samples 
Species matched Species characterisation 
method 
Strain characterisation 
method 
Source 
UK Patients (n=33) 
Isolates (n=36)  
Hospital water 
faucets (n=97), tank 
(n=5) 
57:97 (faucet) 
3:5 (tank) 
36:102 M. xenopi (n=36) Culture 
Unspecified methods 
NA (McSwiggan and 
Collins, 1974) 
USA AIDS patient 
stool, sputum 
and blood (n=36) 
Environmental and 
municipal water 
sources 
10:NA 5:NA M. avium (n=5) Culture  
DNA probe kits (SNAP, 
Gen-Probe) 
PFGE - AseI (Von Reyn et al., 
1994) 
USA Patient blood or 
bone marrow 
(n=40) 
Hospital water  
(n=10) 
House water (n=58) 
Reservoir water 
(n=13) 
10:10 (Hospitals) 
54:58 (Houses) 
12:13 (Reservoirs) 
3:10 (Hospitals) 
2:58 (Houses) 
0:13 (Reservoirs) 
M. avium (n=5) Culture 
Serotyping 
Species specific DNA 
probes (Syngene) 
Multilocus Enzyme 
Electrophoresis 
NA (Glover et al., 1994) 
Canada Patient sputum 
(n=1) 
Hot tub water (n=1) 1:1 1:1 M. avium (n=1) Culture 
Multilocus Enzyme 
Electrophoresis 
 
RFLP (IS1245) 
(Kahana et al., 1997) 
USA Patients (n=17) 
Isolates (n=19) 
Water reservoirs 
(n=13) 
Residential water 
(n=55) 
Commercial 
building water 
(n=31) 
Hospital water 
(n=15) 
12:13 Water 
reservoirs  
45:55 Residential 
water  
31:31 Commercial 
building water  
15:15 Hospital water  
3:144 M. avium (n=3) Culture 
Biochemical analyses 
DNA probe kits (SNAP, 
AccuProbe) 
HPLC 
PFGE - AseI (Aronson et al., 
1999) 
USA AIDS and non-
AIDS patients 
(n=103 isolates) 
Various vegetables 
(n=121) 
25:121 1:121 M. avium (n=1) Culture 
DNA probe kits 
(Accuprobe, SNAP) 
RFLP 
RT-PCR (IS 1245 and 
IS1311) (Avium only) 
(Yoder et al., 1999) 
USA Patient biopsy 
tissue (n=2) 
Nail salon whirlpool 
bath swabs  (n=7) 
3:7 2:7 M. mageritense 
(n=2) 
Culture 
Biochemical analyses 
PCR-RFLP (hsp65) 
HPLC (mycolic acid esters) 
rep-PCR 
PFGE - XbaI 
(Gira et al., 2004) 
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USA Patient sputum 
(n=131) 
(n=161 isolates) 
Hospital hot water 
system isolates 
(n=13) 
13:13 85:13 M. avium (n=85) Culture 
PCR-RFLP (hsp65)  
Gen-probe DNA Probes  
PFGE - AsnI, XbaI (Tobin-D’Angelo et 
al., 2004) 
Australia Patient sputum 
(n=4) 
Spa water (n=2) 2:2 3:2 M. avium (n=3) Culture 
Phenotypic characteristics 
PFGE -  AseI 
rep-PCR (between 
IS1245 and IS1311) 
(Lumb et al., 2004) 
Korea Patient blood 
culture (n=12 
isolates) 
Hospital tap water 
n=100 
50:100 2:100 M. mucogenicium 
(n=2) 
Culture 
PCR-RFLP (ropB) - MspI, 
HaeIII 
RAPD (10-mer primer) (Shin et al., 2007) 
USA Patient sputum 
(n=26) 
Commercial potting 
soil aerosols (n=2) 
Patient garden soil 
aerosols (n=79) 
21:21 3:79 M. intracellulare 
(n=2) 
M. avium (n=1) 
Culture 
RFLP (hsp65) - HaeIII, 
BstEII 
Partial sequencing (16s and 
23s rDNA) 
PFGE - Xbal (De Groote et al., 
2006) 
Japan Patient sputum 
(n=30) 
Patient residential 
bathrooms 
(showerhead water 
(n=46), kitchen tap 
water (n=48), 
bathtub tap (n=48), 
showerhead scale 
(n=37), drain slime 
(n=49) and air 
conditioners (n=45)) 
10:371 (all in 
bathrooms) 
2:49 M. avium (n=2) Culture 
Phenotypic characteristics 
Partial sequencing (16s- 
23s RNA ITS region) 
Serotyping 
RFLP (IS 1245 and IS 
1311) 
PFGE - Xbal, DraI 
(Nishiuchi et al., 
2007) 
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Country Clinical 
samples 
Environment 
investigated 
Environmental 
samples 
containing NTM 
: Number of 
environmental 
samples taken 
Matched clinical 
and 
environmental 
NTM isolates : 
total 
environmental 
samples 
Species matched Species characterisation 
method 
Strain characterisation 
method 
Source 
USA Patient 
sputum (n=1) 
Showerhead sediment 
(n=6), hot (n=6) and 
cold (n=6) bathroom 
tap water 
6:6 (Hot water) 
6:6 (Cold water) 
6:6 (Sediment) 
1:18 M. avium (n=1) Culture 
Partial sequencing (16s 
rDNA) 
RFLP (hsp65 and IS 1245/IS 
1311) - BstEII, HaeIll 
(Falkinham III et al., 
2008) 
USA Patient blood 
(n=5) 
Texas hospital sinks, 
showers (n=13)  
Municipal water tank 
swabs (n=2) 
Municipal water plant 
tanks (n=2) 
Hospital swabs (n=10) 
Ice machine ice (n=1) 
12:27 1:27  M. phocaicum 
(n=1) 
Culture 
Partial sequencing 
(hsp65, 16S rRNA, and 
rpoB) 
rep-PCR (Box A1R Primer) 
RAPD - PCR (RAPD1 
primer) 
PFGE - AseI 
(Cooksey et al., 
2008) 
USA Patient 
isolates 
(n=74) 
Residential water 
supplying patients 
homes (n=23) 
23:23 1:23 M. avium (n=1) Culture 
Multilocus Enzyme 
Electrophoresis  
PFGE - Xbal (Hilborn et al., 2008) 
Spain Patients 
(n=39) 
Patient 
urine(n=23 
isolates) 
Patient 
sputum (n=19 
isolates) 
Hospital tap water 
Urine collection bottles 
6:NA (Hospital 
tap water)  
11:NA (Urine 
bottles) 
21:NA (Patient 
urine) 
5:NA (Patient 
sputum) 
M. avium (n=26) Culture 
Phenotypic characteristics 
DNA Probe kit 
(AccuProbe MAC culture 
identification kit) 
rep-PCR  (IS1245 and IS901) 
Partial sequencing (hsp65, 
16S rDNA) 
RFLP (IS 1311) - HinfI, MseI 
PFGE - Xbal 
(Alvarez et al., 2008) 
USA Patients 
(n=42) 
Patient residential 
water systems (n=37) 
Total samples taken 
(n=394) 
 
22:37 (houses) 
109:394 
(individual 
samples) 
7:37 M. avium (n=7) Culture 
Partial sequencing (16s 
rDNA) 
Rep-PCR  (Falkinham III, 2011) 
USA Patients 
(n=24) 
Patient 
samples 
(n=60) 
Hospital water and ice 
machines (n=139) 
Household water (n=5 
households) 
112:139 
(Hospital water 
and ice) 
4:5 (Residential 
water) 
5:139 (Hospital 
water and ice) 
3:5 (Residential 
water) 
M. porcinum 
(n=8) 
Culture 
HPLC of mycolic acids 
RFLP (hsp65) 
PFGE - Xbal, AseI 
Partial sequencing (hsp65, 
ropB, recA and 16s rDNA)  
(Brown-Elliott et al., 
2011) 
Australia Patients Patient taps, swimming 19:20 7:20 (Species M. abscessus Culture rep-PCR (Thomson et al., 
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(n=20) pools and rainwater 
tanks (n=20) 
level) 
1:20 (Strain 
level) 
(n=3), M. avium 
(n=1), M. 
gordonae (n=1), 
M. lentiflavum 
(n=1), and 
M. kansasii 
(strain level 
match)(n=1) 
RT-PCR and High 
Resolution Melt Curve 
Partial sequencing (16s 
rDNA) 
Multiplex PCR 
Hain Life Sciences 
GenoType 
Mycobacterium AS Kit 
2013a) 
Australia Patients 
(n=68) 
Isolates 
(n=72) 
NTM patient 
residential water swabs 
and aerosols (n=16 
isolates) 
Water from main, 
reservoir and 
distribution points 
(n=220)  
n=16 isolates 
(NTM Patient 
residential water 
swabs and 
aerosols) 
49:220 (Water 
from main, 
reservoir and 
distribution 
points) 
6:65 
(environmental 
isolates) 
M. kansasii (n=6) Culture 
Phenotypic characteristics 
Partial sequencing 
(hsp65, 16s rDNA) 
Multiplex PCR 
DNA probe kit 
(GenoType® 
Mycobacterium AS 
(additional species) kit) 
RFLP (16s-23s ITS rDNA) 
rep-PCR 
(Thomson et al., 
2014) 
Australia Patient 
samples 
(n=74) 
Municipal water 
Tap water 
Tank water 
Swimming pool water 
15:NA 6:15 (water 
isolates) 
M. abscessus 
(n=6) 
Culture 
Phenotypic characteristics 
Partial sequencing (16s 
rDNA, hsp65, rpoB) 
Multiplex PCR 
DNA probe kit 
(GenoType® 
Mycobacterium AS 
(additional species) kit) 
rep-PCR (Thomson et al., 
2013b) 
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3.5) Factors determining clinically important sources of NTM 
 
3.5.1)  Geographic location 
Relevant studies have been conducted in different countries, with a majority from the USA and 
Australia (Table 3) and few from the developing world. The countries best represented in the 
literature have lower prevalence of M. tuberculosis infection, better diagnosis of NTM diseases and 
more funding available for research. The imbalance makes it difficult to address the role of climate 
and geographical location in the acquisition of NTM from water and soil.  NTM does; however, 
appear to be widespread in most regions, as does NTM disease (Griffith et al., 2007, Hoefsloot et 
al., 2013). It remains unclear why  the species causing disease vary between countries, but there is 
potential for climate to influence NTM environmental exposure through the prevalence of NTM in 
the environment (Reed et al., 2006).  
 
3.5.2) Patient exposure 
Many common activities expose individuals to pathogenic NTM. The most studied are hot-tub use 
(Kahana et al., 1997, Lumb et al., 2004, Mangione et al., 2001), showering (Cooksey et al., 2008, 
Falkinham III et al., 2008, Thomson et al., 2013a), faucet use (McSwiggan and Collins, 1974, 
Nishiuchi et al., 2007, Shin et al., 2007) and gardening (De Groote et al., 2006). These sources have 
been investigated by studies matching NTM strains between patient and the environment. NTM 
transmission has also been linked with exposure from commercial farming (Fujita et al., 2013), 
aerosolised metalworking fluids (Shelton et al., 1999) and tending of aquariums (Collier, 2002), but 
these routes have yet to be confirmed by matching clinical and environmental strains. 
 
Sources of residential exposure to NTM have been investigated via questionnaire-based survey 
(Fujita et al., 2014, Maekawa et al., 2011, Reed et al., 2006). Exposure to soil was identified as a 
risk factor in all three studies and one showed an  increase in mixed and polyclonal NTM infections 
in patients regularly exposed to soil, demonstrating the influence of environmental exposure on 
infection incidence within a cohort of  NTM disease patients (Fujita et al., 2014). NTM disease did 
not correlate with exposure to food or pets (Maekawa et al., 2011, Reed et al., 2006).  
 
Although useful data are provided, the use of surveys is flawed in that: 1) One exposure event may 
be enough for NTM colonisation, making  accounts of activity frequency less relevant; 2) isolates 
were not matched to ascertain that the source implicated was responsible for NTM disease; 3) for a 
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study of the general population, a cohort of 800 is insufficient in an area with a NTM infection rate 
of 1.2/100, 000 (Reed et al., 2006). Some studies have used sensitin skin testing as an indicator of 
NTM infection (Reed et al., 2006). Sensitin tests reflect both past and current infections, with 
potential for false positives, and are poor markers of clinical disease. 
 
The low ratio of successful matches between environmental and clinical isolates is striking. While 
some studies matched most clinical isolates with their reservoir (Falkinham III et al., 2008, Lumb et 
al., 2004), this is likely due to low numbers of participating patients. Others achieved accurate 
matches with fewer than 20% of patient isolates, so any conclusions regarding relative 
environmental risk factors are broad extrapolations (Cooksey et al., 2008, De Groote et al., 2006, 
Nishiuchi et al., 2007, Shin et al., 2007). The reservoirs for most clinically infective NTM remain 
unknown, but many bacteria in the patient’s immediate environment are never identified and 
characterised. The missing pathogens may have originated from a known environment of interest 
(e.g.: showerhead) not sampled for the study, or may have been transmitted via a novel route. The 
significant lag time between acquisition of infection and diagnosis of disease (1-10 years) makes it 
difficult to pin-point potential sources, as the environment may have changed by the time of 
diagnosis.   
 
Alternatively, human transmission may be responsible for more infections than previously 
suspected. Although this has rarely been observed, recent studies show links between isolates from 
multiple patients (Aitken et al., 2012, Bryant et al., 2013, Ricketts et al., 2014). These results do not 
prove human to human transmission, as patients may have acquired the pathogen from the same 
environmental reservoir, however, this route of NTM infection should not be dismissed without 
further study. 
 
3.5.3) Species and strain infective potential vary 
Species of NTM differ in habitat and in their potential for human infection. A summary compiled by 
the American Thoracic Society shows the relative risk of infection by different NTM species in the 
USA (Griffith et al., 2007). M. kansasii remains one of the most infective species whilst others (ie: 
M. frederiksbergense, M. flavescens, M. moriokaense) appear to be non-pathogenic to humans 
(Griffith et al., 2007).   
There is also evidence to suggest pathogenicity may vary between strains of the same species. In a 
study of clinical isolates of M. kansasi (n=191), isolates from different subtypes differed in 
pathogenicity based on the percentage of patients infected (Taillard et al., 2003).  Subtype 1 
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accounted for a majority of isolates and was considered pathogenic in 81% of cases, while subtype 
3 was only pathogenic in 6% of cases and was generally considered a non-pathogen (Goy et al., 
2007). 
Antibiotics play a central role in the treatment of NTM disease, with individual NTM species and 
patients requiring different antibiotic cocktails. Difficulties prescribing the correct treatment arise 
from the limited ability of in vitro susceptibility tests to predict antimicrobial responses for all NTM 
species. For example, M. kansasii is susceptible to multiple antibiotics and M. avium is susceptible 
to the macrolide antimicrobials in vivo, but M. abscessus subs abscessus has inducible resistance to 
macrolides (Griffith et al., 2007). In rare cases, side effects of effective antibiotic treatment 
outweigh the consequences of the disease.  
 
Strain typing of NTM is not routine clinical care, but could reveal patterns of pathogenicity and 
antibiotic resistance present in the population. For example, M. abscessus strains with a functional 
erythromycin ribosome methyltransferase (erm) gene are resistant to macrolide antibiotics. Strains 
lacking a functional erm gene are susceptible to macrolides in vivo and in vitro (Nash et al., 2009).  
 
 
3.6) Understanding NTM transmission will facilitate targeted prophylactic measures 
NTM are ubiquitous in the environment and vary in infectivity, pathogenicity and susceptibility to 
antibiotics. Although most studies using high resolution molecular techniques are from the USA and 
Australia, NTM have been isolated from similar sources in other countries and climates. The risk of 
a particular environmental source transmitting pathogenic NTM is determined by three variables. 1) 
The capacity for pathogenic NTM growth in the environment. 2) The frequency of human exposure 
from the source in question. 3) The method of patient exposure to pathogenic NTM from the source. 
Environments of interest are those with high NTM burdens in a form that is easily aerosolised, 
namely showers, hot tubs, garden soil and house dust. 
 
From studies in which environmental NTM have been matched by strain to pathogenic isolates, key 
sources appear to be hot-tubs, faucets and showerheads, with similar frequencies of isolation from 
hospitals and private residences.  Most private residences sampled, however, belonged to patients 
already infected with NTM. When private residences of uninfected individuals were sampled, NTM 
were recovered at a much lower frequency suggesting a relatively low risk of infection from 
household water (Nishiuchi et al., 2007).  
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Whilst many studies confirm that NTM is transmitted from water, this may simply reflect the large 
number of water-based studies. M. avium has a long-standing link to water environments, as does 
M. abscessus (Thomson et al., 2013a). Although M. kansasii, can be found in a tap water, few 
strains from tap water matched disease isolates. M. intracellulare infections were also associated 
with water, but these waterborne M. intracellulare isolates have since been reidentified as a novel 
species, M. chimaera (Tortoli et al., 2004). Although M. intracellulare infection is still commonly 
reported (Carter et al., 2014), since this development there remains no evidence linking water to M. 
intracellulare infection. Alternative transmission pathways for these mycobacteria may include soil 
exposure, which correlates with NTM pulmonary disease in multiple studies (Fujita et al., 2014, 
Ichiyama et al., 1988, Maekawa et al., 2011, Reed et al., 2006) although it has only been confirmed 
as a transmission route via strain-matching in one (De Groote et al., 2006). 
Presently, prophylaxis of pulmonary NTM disease involves avoidance of exposure to possible NTM 
containing aerosols. Steps that can be made to reduce levels of NTM from water include 
maintaining hot water system temperatures at above 60C and correct pH and chlorination in pools 
and spas. Nosocomial infections can be prevented by cleaning medical instruments using only 
sterile water and disinfectant before use, and use of personal protective equipment can aid in 
prevention of aerosol inhalation in areas of high exposure, e.g.: when gardening. These precautions 
can be recommended to individuals perceived to be at the greatest risk of infection. A more 
extensive understanding of NTM transmission will allow more targeted prophylactic measures.  
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Chapter 4: 
Do polymorphisms in IL10 influence 
pulmonary NTM disease susceptibility? 
 
 
This section of work investigates SNP of interest within IL10 in patients of pulmonary disease and 
healthy controls. This association study follows on from previous work done by our lab (Affandi et 
al., 2013) and identifies two SNP alleles in LD  associating significantly with disease.    
 
 
Full citation: Halstrom, S., Thomson, R., Goullee, H., Baltic, S., Allcock, R., Temple, S. E., & 
Price, P. 2017a. Susceptibility to non-tuberculous mycobacterial disease is influenced by rs1518111 
in IL10. Human Immunology, 78(4), 391-393. PMID: 28174026. 
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Abstract 
Although exposure to potentially pathogenic non-tuberculous mycobacteria (NTM) via soil and 
domestic water supplies is common, pulmonary infection and disease are confined to a small 
proportion of older individuals. We have associated alleles of a polymorphism in IL10 (rs1800896) 
with NTM disease and shown that blood leukocytes from patients with NTM produce high levels of 
IL-10. Here we investigate seven additional polymorphisms in IL10 in a larger cohort of Caucasian 
controls and patients with pulmonary NTM disease. We show a significant association between 
pulmonary NTM disease and one polymorphism (rs1518111) in strong linkage disequilibrium with 
rs1800896.  
 
 
4.1) Introduction 
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Pulmonary disease is the most common presentation of infections with non-tuberculous 
mycobacteria (NTM) in otherwise healthy adults, and is considered an emerging health risk in 
Australia and around the world (Thomson, 2010, Winthrop et al., 2010). Exposure through soil or 
water is common, but few people develop pulmonary NTM disease. Estimates from Queensland, 
Australia, suggest a frequency of 22.1 persons per 100 000 in the population (Thomson, 2010). 
Known risk factors for disease include smoking, excessive alcohol intake, past tuberculosis and 
underlying lung diseases such as COPD and bronchiectasis (Cassidy et al., 2009, Winthrop et al., 
2010). However these factors do not account for all cases – a notable exception being patients with 
the "Lady Windermere" phenotype. These individuals are lean and tall, with higher than normal 
incidence of thoracic abnormalities including scoliosis, pectus excavatum and mitral valve prolapse. 
The majority of pulmonary NTM cases are Caucasian (91%) and female (95%), with an average age 
of 60 years (Kim et al., 2008). Behavioural questionnaires found no links between pulmonary NTM 
disease and patients’ activities, exposures or habits (Kim et al., 2008). Genetic factors should be 
investigated further. 
 
Effective Th1 and Th17 cell-mediated immune responses are crucial for the clearance of NTM 
infection and can be inhibited by Th2 cytokines such as IL-10. Hence polymorphic alleles affecting 
either the expression or activity of IL10 may impact upon the Th1/Th2/Th17 balance/response in 
patients of pulmonary NTM disease. Our studies of cytokine production by blood leukocytes from 
patients with pulmonary NTM disease demonstrated comparatively high IL-10 responses (Lim et 
al., 2010). Interferon-γ/IL-10 ratios are also associated with disease severity in tuberculosis, further 
suggesting a role for IL-10 (Jamil et al., 2007). 
 
Previously, we and others have linked differences in allele frequencies for single nucleotide 
polymorphisms (SNP) within the IL10 promoter with pulmonary NTM disease (rs1800896), asthma 
and tuberculosis (rs1800896, rs1800871, and rs1800872) (Affandi et al., 2013, Gao et al., 2015, 
Hsia et al., 2015, Liu et al., 2015). To further understand the influence of genetics on disease, we 
typed seven additional SNP within IL10 in an expanded cohort of patients with pulmonary NTM 
and healthy controls. 
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4.2) Materials and Methods 
4.2.1) Patients and controls 
DNA was obtained from 124 Caucasian patients with pulmonary NTM disease attending 
Greenslopes Private Hospital, QLD, Australia and Prince Charles Hospital, QLD, Australia between 
2005 and 2014. NTM infection was diagnosed according to American Thoracic Society criteria 
(Griffith et al., 2007) using radiological and microbiological findings. All participants provided 
written informed consent and the project was approved by the Greenslopes Research and Ethics 
Committee (Protocol 12/12) in accordance with the National Statement on Ethical Conduct in 
Human Research. 229 control donors were recruited from Western Australia(Temple et al., 2003) 
and DNA samples were provided by the Institute for Respiratory Health, Western Australia, in 
accordance with a Royal Perth Hospital Human Research Ethics Approval. The cohort are 
considered to be representative of the Caucasian Australian population from which patients were 
also derived. 
 
4.2.2) Genotyping 
DNA samples were quantified by fluorometry with a Qubit fluorometer (Thermo Fisher Scientific, 
Waltham, MA, USA) and adjusted to 50ng/uL. Genotyping was performed using custom TaqMan 
OpenArray Genotyping Plates (Life Technologies, Grand Island, NY, USA) (Goullee et al., 2016). 
DNA samples were diluted at 1:1 in TaqMan OpenArray Genotyping Master Mix for 50 cycles of 
PCR amplification. The output was viewed using OpenArray™ SNP Genotyping Analysis 
software, and genotypes were allocated manually. The SNP rs3024497 was excluded as it did not 
meet Hardy-Weinberg Equilibrium (HWE). The genotyping success rate for the remaining SNP 
averaged 94.4 %. 
 
4.2.3) Data analysis 
Linkage between paired SNP alleles was determined with the use of Ensembl’s “Pairwise linkage 
disequilibrium data by population” tool with the 1000 genomes database. In this way, linkage is 
determined via both R
2
 and D` values for each ethnicity with available data. Statistical analyses 
were performed in Stata 12 (StataCorp, Collage Station, TX, USA). Univariate analyses evaluating 
associations between pulmonary NTM lung disease and gender, age, SNP and haplotypes were 
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performed using two-tailed Fisher’s exact or Chi2 tests (χ2) as appropriate. Multivariate analyses 
were performed using logistic regression modelling using all included factors associated with NTM 
in univariate analyses (p < 0.20 cut-off) followed by a stepwise removal procedure to obtain the 
model of best fit. 
 
4.3) Results 
4.3.1) The demographic profile of patients with pulmonary NTM disease 
We studied 124 patients with pulmonary NTM disease and 229 healthy controls of Caucasian 
ethnicity. Seventy-three percent of patients and 55% of healthy controls were female. As this was a 
statistically significant difference (χ2, p = 0.001), gender was included in logistic regression models 
with SNPs of interest.  
 
NTM patients were older than healthy controls [median (range) 67 (25-89) vs. 44 (21-75) years, 
respectively]. Whilst some control donors may develop pulmonary NTM lung disease later in life, 
the impact on the data is likely to be minor as pulmonary NTM disease is rare. Patients were 
infected with M. intracellulare (n = 64), M. avium (n = 13), M. abscessus (n = 10), M. kansasii (n = 
3), M. triplex (n = 2), M. xenopi (n = 1), M. simiae (n = 1), M. interjectum (n = 1), M. shimoidei (n = 
1), M. terrae (n = 1), M. gordonae (n = 1), or M. lentiflavum (n = 1). Some individuals were 
infected with more than one mycobacterial species (n = 12). 
 
4.3.2) Associations between SNP genotypes and pulmonary NTM disease 
Of the seven SNP analysed, rs1518111 was the only marker showing a statistically significant 
association with pulmonary NTM disease (P =0.004) in univariate χ2 analysis. This withstood 
Bonferroni correction for multiple comparisons (Table 4).  
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Table 4: IL10 SNP associated with NTM disease in univariate analyses 
SNP 
 a
 
Chr. 1 
Position 
MA 
MAF 
b
 
Control 
MAF 
b 
NTM 
P-value 
(χ2) 
   (n = 229) (n = 124)  
rs3024498 206941529 G 43.7% 54.9% 0.054 
rs1518111 206944645 A 43.7% 27.6% 0.004 
rs3021094 206944952 C 15.7% 18.5% 0.520 
rs3024491 206945046 G 27.0% 22.1% 0.320 
rs1800872 206946407 A 46.4% 35.8% 0.058 
rs1800871 206946634 T 46.6% 38.5% 0.150 
a 
SNP are shown in chromosomal order. 
b 
Minor allele frequencies are based on individuals successfully genotyped for each SNP 
 
rs03024498 and rs1800872 displayed weaker associations with disease (χ2, P < 0.06). These three 
SNP were included in logistic regression models with gender. After a stepwise removal process, the 
final model (model p < 0001; R
2
 = 0.05) included only gender and rs1518111 (Table 4.5). When 
gender was not included, the model was weakened but remained comparable, demonstrating the 
associations between the minor alleles of rs1518111 and rs3024498 with reduced and increased risk 
of disease (Table 5).  
 
 
Table 5: Logistic regression models define gender and rs1518111 as predictors of NTM disease. 
Variable Odds Ratio P-value 95% confidence interval 
Model combining gender and SNP (n = 338
 a
, p < 0.0001; R
2
 = 0.05) 
Gender  0.440 0.001 0.266-0.718 
rs1518111  0.507 0.007 0.309-0.830 
Model combining SNP (n = 315
 a
, p = 0.0087; R
2
 = 0.02) 
rs3024498 1.370 0.205 0.840-2.251 
rs1518111
 
 0.540 0.021 0.320-0.910 
a 
excluding samples with genotyping failures. 
 
We assessed whether radiological findings (nodular bronchiectasis, cavitary, or mixed) were 
associated with alleles of the rs1518111 SNP. Cavitary disease was more common in patients 
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carrying the minor allele (A) at rs1518111 (χ2, P = 0.001). The isolation of fast (n=9) or slow 
(n=86) growing mycobacteria from the lung were also tested for associations with alleles of 
rs1518111. A weak association was observed between fast growing NTM species and carriage of 
the minor allele (χ2, P = 0.07). 
 
4.4) Discussion 
The minor (A) allele of rs1518111 (previously denoted rs3748675) was associated with reduced 
risk of pulmonary NTM disease. This minor (A) allele has been linked to increased incidence of 
Behcet’s disease in a Turkish cohort (Remmers et al., 2010),  reduced risk of prostate hyperplasia in 
a Korean cohort (Yoo et al., 2011), and increased risk of tuberculosis (as part of a three SNP 
haplotype) in an Ugandan cohort (Stein et al., 2007). The allele is also associated with lower IL-10 
plasma concentrations, poor treatment outcome and enhanced systemic inflammation in patients 
with acute coronary syndrome in a Swedish cohort (Mälarstig et al., 2008).  Studies investigating 
this allele as a contributing factor to disease identify associations with pro-inflammatory tendencies 
in patients, suggesting a modified IL-10 response. Our study implicates the minor (A) allele of 
rs1518111 in risk of pulmonary NTM disease in Caucasians.  
 
Ethnicity is an important consideration because the frequency of the A allele of rs1518111 varies 
between different ethnicities, from 22% in Europeans (EUR) to 68% in East Asians (EAS) 
(Consortium, 2015). rs1518111 is in linkage disequilibrium with rs1800896 in all ethnicities 
covered by the 1000 Genomes database (D’ > 0.99) (Consortium, 2015). However R2 values differ 
between ethnicities, from 0.095 (Chinese Dai in Xishuangbanna, China) to 0.420 (Mandinka in 
Western Gambia). The minor (C) allele of rs1800896 is usually inherited with the minor (A) allele 
of rs1518111, but rs1800896 has a higher MAF. Both alleles have now been associated with NTM 
disease (Affandi et al., 2013), demonstrating the existence of an IL10 haplotype which could affect 
the ability of an individual to respond effectively to pulmonary NTM infection.  In individuals from 
the population used in our study, a haplotype spanning the promotor region of IL10 affected 
transcription regulation in peripheral blood cells stimulated with Streptococcus pneumonia (Temple 
et al., 2003). The two SNP associated here with NTM disease (rs1800896 and rs1800872) were in 
complete linkage disequilibrium (Temple et al., 2003). In South African HIV patients, we have 
associated rs1800896 (Wadley et al., 2013) and rs1518111 (Goullee et al, unpublished data) with 
peripheral neuropathy, further demonstrating a link with inflammatory disease for these SNP 
alleles. 
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Radiological data was available for a subset of the patients used in this study. The majority (76.6 %) 
of patients presented with nodular bronchiectasis. Where this condition fits in the pathogenicity of 
NTM infection is still debated, but in many cases clear progression of radiological changes occurs 
after NTM is isolated, and very often in the absence of other pathogens. Very few of the patients 
were  known to have had bronchiectasis before the diagnosis of pulmonary NTM infection, in the 
majority it is believed to have developed as a result of NTM infection rather than being a precursory 
condition. Carriage of the minor (A) allele at rs1518111 correlated with a presentation of cavitary 
disease (as opposed to nodular bronchiectasis) so the immunopathology of these presentations may 
differ. Infection with fast and slow growing NTM species is independent of radiological 
presentation and only weakly associated with the IL10 genotype. 
 
In conclusion, when compared with a healthy control group, patients with pulmonary NTM disease 
were less likely to carry the minor (A) allele for the IL10 SNP rs1518111, which is in linkage 
disequilibrium with rs1800896 – a SNP previously associated with NTM disease. Our review of the 
literature associates these alleles with low levels of IL-10 and enhanced risk of inflammatory 
conditions. 
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Chapter 5 
Do polymorphisms in the P2X7R-P2X4R-
CAMKK2 region influence pulmonary NTM 
disease susceptibility? 
 
 
This section of work consists of an investigation of genes in the P2X7R-P2X4R-CAMKK2 region 
in patients of pulmonary NTM disease and healthy controls. SNP genotypes are investigated 
individually and collectively within a multi-gene haplotype with the goal of identifying relevant 
associations between genotype and disease. 
 
 
Full citation: Halstrom, S., Cherry, C. L., Black, M., Thomson, R., Goullee, H., Baltic, S., ... & 
Price, P. 2017b. A haplotype spanning P2X7R, P2X4R and CAMKK2 may mark susceptibility to 
pulmonary non-tuberculous mycobacterial disease. Immunogenetics, 1-7. PMID: 28233049. 
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Abstract 
Despite widespread exposure to potentially pathogenic mycobacteria present in the soil and in 
domestic water supplies, it is not clear why only a small proportion of older women contract 
pulmonary non-tuberculous mycobacterial (NTM) infections. Here we explore the impact of 
polymorphisms within three genes; P2X7R, P2X4R and CAMKK2 on susceptibility. 
Thirty single nucleotide polymorphisms (SNP) were genotyped in NTM patients (n = 124) and 
healthy controls (n = 229).  Weak associations were found between individual alleles in P2X7R and 
disease, but were not significant in multivariate analyses adjusted to account for gender. Haplotypes 
spanning the three genes were derived using the fastPHASE algorithm. This yielded 27 haplotypes 
with frequencies >1% and accounting for 63.3% of the combined cohort. In univariate analyses, 
seven of these haplotypes displayed associations with NTM disease above our preliminary cut-off 
(p ≤ 0.20). When these were carried forward in a logistic regression model, gender and one 
haplotype (SH95) were independently associated with disease (model p < 0.0001; R
2 
= 0.05). 
Examination of individual alleles within these haplotypes implicated P2X7R and CAMKK2 in 
pathways affecting pulmonary NTM disease. 
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5.1) Introduction 
Pulmonary disease is the most common presentation of infections with non-tuberculous 
mycobacteria (NTM) in otherwise healthy adults. Hence NTM are considered an emerging public 
health risk in Australia and around the world (Thomson, 2010, Winthrop et al., 2010). Exposure 
through soil or water is extremely common but only a small subset of the population develops 
pulmonary NTM disease. Estimates in Queensland, Australia, suggest 22.1 persons per 100 000 in 
the population will develop disease (Thomson, 2010). Known risk factors include smoking, 
excessive alcohol intake, past tuberculosis, and underlying structural lung disease such as COPD 
and bronchiectasis (Cassidy et al., 2009, Winthrop et al., 2010). However these factors do not 
account for all cases – a notable exception being patients with the "Lady Windermere" phenotype. 
These individuals are lean and tall, with higher than normal incidence of thoracic abnormalities 
including scoliosis, pectus excavatum and mitral valve prolapse. The majority of cases are 
Caucasian (91%) and female (95%), with an average age of 60 years (Kim et al., 2008). 
Behavioural questionnaires found no links between pulmonary NTM disease and patients’ 
activities, exposures or habits (Kim et al., 2008). Genetic factors should be investigated further. 
The risk of pulmonary NTM disease is increased in individuals carrying certain alleles of genes 
encoding cytokines including IL-10, TNFα and IL-28B (Affandi et al., 2013). Other studies have 
linked polymorphisms in natural-resistance-associated macrophage protein 1 (NRAMP1) and cystic 
fibrosis transmembrane conductance regulator (CFTR) to increased risk of NTM disease (Jang et 
al., 2013, Kim et al., 2008, Koh et al., 2005, Tanaka et al., 2007, Ziedalski et al., 2006). Mendelian 
susceptibility to mycobacterial disease (MSMD) is an identified syndrome and is associated with 
polymorphisms found in multiple genes involved in IFN-γ dependent immunity (IFNGR1, IFNGR2, 
STAT1, IL12B, IL12RB1, ISG15, IRF8, NEMO and CYBB) (Al-Muhsen and Casanova, 2008, 
Bustamante et al., 2014), but these polymorphisms have not been linked with pulmonary NTM 
disease. Genes of relevance showing no genetic associations with pulmonary NTM disease risk also 
include VDR, IFNGR1 and TLR2 (Huang et al., 1998, Park et al., 2008a, Park et al., 2008b, Ryu et 
al., 2006). An intronic microsatellite repeat polymorphism in TLR2 (Yim et al., 2008) has been 
linked with pulmonary NTM disease. 
No study yet has investigated possible associations between polymorphisms in P2X4R, P2X7R, 
CAMKK2 and pulmonary NTM disease risk. Their potential for modulation of the inflammatory 
immune response make them viable candidates. In particular, P2X7R has been associated with 
aggressive tuberculosis presentations, P2X4R and CAMKK2 are important in macrophage function 
and activated killing of phagocytosed bacteria (central to mycobacterial disease pathogenesis) and 
all three lie in a cluster on chromosome 12 exhibiting some measure of linkage disequilibrium.  
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The P2X7R gene encodes the purinergic receptor P2X ligand gated ion channel 7 (P2X7R) protein, 
an ATP-gated ion channel which plays an important role in the innate immune response. When 
bound by its ligand, extracellular ATP, P2X7R enables the intracellular killing of phagocytosed 
bacteria (e.g. NTM) in the presence of local inflammatory stress. An important role for the P2X7R 
has been identified in aggressive forms of tuberculosis (Amaral et al., 2014, Ge and Chen, 2016, 
Wu et al., 2014). A P2X7R knockout mouse model implicated P2X7R in M. tuberculosis infection 
(Santos et al., 2013). These data make P2X7R a candidate for modulation of NTM disease. 
P2X4R plays a similar role to P2X7R in immune regulation. The gene encodes the purinergic 
receptor P2X ligand gated ion channel 4 (P2X4R) protein, a purinoreceptor activated by ATP 
allowing the transport of calcium ions across a membrane. P2X4R is generally co-expressed with 
P2X7R in intracellular lysosomal compartments of macrophages and microglia, but can be rapidly 
trafficked to the surface membrane via the process of endolysosomal secretion (Stokes and 
Surprenant, 2009). P2X4R appears to be involved in the process of phagocytosis, lysosomal 
destruction and removal of pathogens taken up by macrophages, specifically post-fusion phase 
exocytosis (Miklavc et al., 2011). Polymorphisms in P2X4R may allow NTM to exploit this system, 
and so persist in macrophage phagosomes via inhibition of lysosome binding. 
CAMKK2 encodes the Calcium/Calmodulin-Dependent Protein Kinase Kinase 2 beta (CaMKK2) 
protein, a calcium ion activated protein kinase involved in many different pathways, including 
lymphocyte activation. CaMKK2 may act downstream of P2X4R in the process of exocytosis in 
macrophages that have taken up NTM, with P2X4R allowing calcium ions to traverse cell 
membranes activating Calmodulin-dependant pathways. This function may be affected by total or 
partial loss-of-function mutations leading to an increased susceptibility to NTM. CAMKK2 is 
selectively expressed at higher than base levels in monocytes, macrophages and B-lymphocytes 
(Racioppi et al., 2012). In knockout mice, CAMKK2-null macrophages displayed deficiencies in 
motility, phagocytosis of bacteria and synthesis of cytokines in response to the TLR4 agonist 
lipopolysaccharide (LPS) (Racioppi et al., 2012). Loss of CaMKK2 function uncouples the TLR4 
cascade, thereby failing to properly activate the inflammatory response. Poor macrophage function 
in CAMKK2 knockout-mice establishes the potential for mutations in this gene to affect NTM 
disease. 
Here, SNP and haplotypes spanning P2X7R, P2X4R and CAMKK2 are investigated for associations 
with the incidence of pulmonary NTM disease in Caucasians. Associations were corrected for the 
disproportionate incidence of pulmonary NTM disease between genders.  
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5.2) Materials and Methods 
5.2.1) Patients and controls 
DNA was obtained from Caucasian patients attending Greenslopes Private Hospital, and Prince 
Charles Hospital with pulmonary NTM disease between 2005 and 2014. All participants provided 
written informed consent to participate in this work, which was approved by the Greenslopes 
Research and Ethics Committee (Protocol 12/12) in accordance with the National Statement on 
Ethical Conduct in Human Research. Control samples were supplied by the Institute for Respiratory 
Health, Western Australia, in accordance with the Royal Perth Hospital Human Research Ethics 
Committee. This cohort is representative of the Caucasian Australian population from which 
patients were also derived. 
5.2.2) Genotyping 
DNA samples were quantified with Qubit Fluorometric Quantitation technology (Thermo Fisher 
Scientific, Waltham, MA, USA) and adjusted to 50 ng/uL. Genotyping was performed using 
TaqMan OpenArray Genotyping Plates (Life Technologies, Grand Island, NY, USA) (Goullee et 
al., 2016). DNA samples were diluted at 1:1 in TaqMan OpenArray Genotyping Master Mix for 50 
cycles of PCR amplification. The output was viewed using OpenArray™ SNP Genotyping Analysis 
software, and genotypes were allocated manually. Several SNP were excluded from further analysis 
due to not meeting Hardy-Weinberg Equilibrium (HWE) or having a high percentage of no call 
readings (rs11065456, rs208294, rs208307, rs12299020, rs504677, rs10160951, rs2230912, 
rs2668252, rs11608486, rs1169719, rs11065502, rs11065503, rs11837114, rs1718120 and 
rs2686367). 
5.2.3) Haplotype construction 
Haplotypes were identified using the fastPHASE algorithm (Scheet and Stephens, 2006). As per 
convention, the most frequent allele in the population is denoted 0, with the “minor” allele denoted 
1. This system is used to portray haplotypes in this study. During haplotype construction, multiple 
possible haplotypes were generated with fastPHASE for each individual based on their genotypes. 
The most probable combination of haplotypes for each were selected. From these, 188 different 
haplotypes were identified from the combined patient and control samples (n=353). Haplotypes 
with a combined frequency of 1% or less across patient and control populations were excluded from 
further analysis.  
5.2.4) Statistical analyses 
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Statistical analyses were performed in Stata 12 (StataCorp, Collage Station, TX, USA). Univariate 
analyses evaluating associations between pulmonary NTM lung disease and gender, age, SNP and 
haplotypes were performed using two-tailed Fisher’s exact or Chi2 tests (χ2) as appropriate. 
Multivariate analyses were performed using logistic regression modelling where all included factors 
associated weakly with NTM in univariate analysis (p < 0.20 cut-off chosen for this exploratory 
study) followed by a stepwise removal procedure to obtain the model of best fit. 
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5.3) Results 
5.3.1) The demographic profile of patients with pulmonary NTM disease 
Samples were available from 124 patients with pulmonary NTM disease (attending clinics at The 
Prince Charles and Greenslopes Private Hospitals, Queensland, Australia) and 229 healthy controls 
(resident in Western Australia). All participants were of Caucasian ethnicity. 73% of patients and 
55% of healthy controls were female. As this is a significant difference (χ2, p = 0.001), gender was 
included in logistic regression models for SNP and haplotypes of interest.  
NTM patients were older than healthy controls [median (range) 67 (25-89) vs. 44 (21-75) years 
respectively]. Whilst some control donors may develop pulmonary NTM lung disease later in life, 
the impact on the data is considered minor as pulmonary NTM disease is rare. Patients displayed 
infections from M. intracellulare (n = 64), M. avium (n = 13), M. abscessus (n = 10), M. kansasii (n 
= 3), M. triplex (n = 2), M. xenopi (n = 1), M. simiae (n = 1), M. interjectum (n = 1), M. shimoidei (n 
= 1), M. terrae (n = 1), M. gordonae (n = 1), or M. lentiflavum (n = 1). Some individuals were 
infected with more than one mycobacterial species (n = 12). 
 
5.3.2) Associations between SNP genotypes and pulmonary NTM disease 
Of the SNP tested, four in P2X7R (rs208288, rs1718125, rs1186055 and rs2857585) were weakly 
associated with pulmonary NTM disease (P < 0.20) in univariate χ2 analysis. These SNP and 
gender met our criteria for inclusion in logistic regression modelling (Tables 5.1 and 5.3). The 
optimal model (model p = 0.0004; R
2
=0.027) did not retain any SNP, only gender. No SNP from 
P2X4R or CAMKK2 were associated with NTM in univariate analyses (P > 0.20). 
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Table 6: No SNP associated with NTM in univariate analyses. 
3’dwns: 3’ downstream region, 5’ups: 5’ upstream region, 3'utr: 3' untranslated region, 5'utr: 5' untranslated 
region, MA: minor allele in this cohort, MAF: minor allele frequency. 
 
a 
SNP not in Hardy-Weinberg equilibrium were excluded. Remaining SNP are shown in chromosomal order 
(same as the order of appearance in the haplotypes). 
b 
Four SNP carried forward into multivariable analyses are marked with shading 
c 
Minor allele frequencies generated are based on the number of individuals carrying each allele, so patients 
with no calls for a particular SNP are excluded from the frequency calculations. 
SNP 
 a
  Region MA 
MAF 
c
  MAF 
c
 P-value 
Position Control  NTM  (χ2) 
P2X7R 
rs10849849 121586395 Intronic G  6.6 % 7.0 % 0.90 
rs208288 
b
 121588088 3'dwns G  19.5 %  12.8 % 0.14 
rs17525767 121588125 3'dwns T  21.2 %  21.7 % 0.91 
rs1718125
  b
 121593019 Intronic T  26.2 %  19.5 % 0.16 
rs1169737 121600294 Exonic T  5.3 % 7.4 % 0.43 
rs1186055
 b
 121600529 3'dwns C  47.8 %  39.2 % 0.13 
rs2857585
 b  
 121600802 3'dwns G  14.3 %  9.4 % 0.19 
rs208296 121600953 3'dwns G  45.4 %  42.9 % 0.65 
rs11065464 121602135 3'dwns C  45.8 %  50.9 % 0.38 
rs503720 121605074 3'dwns G  45.5 %  40.0 % 0.33 
rs1653609 121605919 3'dwns C  25.4 %  21.4 % 0.46 
rs2230911 121615131 Exonic G  11.7 %  13.7 % 0.59 
rs3751144 121622239 Exonic T  11.2 %  14.4 % 0.39 
rs3751143 121622304 Exonic C  33.9 %  31.7 % 0.67 
rs12301635 121624108 3'dwns G  20.0 %  14.6 % 0.21 
P2X4R 
rs2686387 121648870 5'ups G  48.0 %  43.3 % 0.41 
rs2303998 121655063 Exonic G  4.0 %  5.7 % 0.47 
rs7298368 121659684 5’ups T  29.9 %  33.3 % 0.51 
rs25643 121660787 Exonic T  31.5 %  27.9 % 0.47 
rs10849860 121668254 3'dwns T  28.1 %  30.6 % 0.63 
CaMKK2 
rs1653587 121676232 3'utr G  12.0 %  13.3 % 0.73 
rs1653588 121676666 3'utr T  11.6 %  11.4 % 0.96 
rs7961979 121671261 3'dwns C  27.0 %  24.8 % 0.66 
rs11065504 121680460 3'dwns G  44.3 %  46.2 % 0.74 
rs7975295 121689101 3'dwns T  20.7 %  21.5 % 0.87 
rs2686344 121690548 Intronic T  46.7 %  40.3 % 0.26 
rs1560568 121690587 3'dwns G  19.5 %  22.8 % 0.47 
rs7314454 121698785 5'ups T  19.1 %  16.4 % 0.54 
rs3817190 121712077 Exonic A  40.3 %  35.6 % 0.44 
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5.3.3) Associations between haplotypes and pulmonary NTM disease 
From the 30 SNP analysed, 188 unique haplotypes were generated by fastPHASE. Haplotypes 
present in less than 1% of the cohort were excluded, leaving 27 haplotypes of interest. One 
haplotype (SH95) was significantly associated with pulmonary NTM disease (χ2, P = 0.019) on 
univariate analysis (Table 7). Seven haplotypes (SH5, SH11, SH17, SH70, SH83, SH95 and SH97) 
displayed associations above our exploratory cut-off (p ≤ 0.20) on univariate analysis and were 
included in logistic regression models with gender (Table 7). After a stepwise removal process, the 
final model (model p < 0.0001; R
2
 = 0.05) included haplotypes SH95, SH70 and gender (Table 
5.3). The haplotype most strongly associated with NTM disease in multivariate analysis was SH95.  
Associations between haplotypes and NTM disease were similar when gender was excluded as a 
variable (model p = 0.0013; R
2
 = 0.04) (Table 5.3).  
 
The results of patient radiological findings (nodular bronchiectasis, cavitary, or mixed) (χ2, P = 
0.631) and mycobacterial isolates from the lung (fast or slow growing species) (χ2, P = 0.590) were 
tested for an elevated co-incidence with SH95. No associations were observed. 
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Table 7: No haplotype associated with NTM in univariate analyses. 
Haplotype  
(SH 
number) 
Haplotype sequence
a
 
 
Frequency
b
 
Controls 
(n=229) 
Frequency 
NTM  
(n=124) 
P-value  
(χ2 )d 
SH6 000000000010000000100010000011 45 (19.6 %) 22 (17.7 %) 0.662 
SH11
c
 000000000000010000000000010000 31 (13.5 %) 11 (8.9 %) 0.196 
SH1 000000011100000000000001000000 28 (12.2 %) 14 (11.3 %) 0.795 
SH2 000000011000000000000001000000 27 (11.8 %) 13 (10.5 %) 0.712 
SH5
 c
 000000011100000000000001000011 22 (9.6 %) 18 (14.5 %) 0.165 
SH9 001001100110000100110000000000 11 (4.8 %) 8 (6.4 %) 0.512 
SH27 000000000110001000000001000000 10 (4.4 %) 7 (5.6 %) 0.592 
SH47 000001010110000101101100000010 10 (4.4 %) 6 (4.8 %) 0.839 
SH74 001001000110000100110000000011 9 (3.9 %) 7 (5.6 %) 0.460 
SH20 000000000100000000000001010000 8 (3.5 %) 6 (4.8 %) 0.536 
SH83
 c
 100101000011100101100000101000 11 (4.8 %) 2 (1.6 %) 0.151 
SH8 000000000000010101100000101000 6 (2.6 %) 6 (4.8 %) 0.272 
SH19 000000000010000100110000000000 7 (3.1 %) 5 (4.0 %) 0.629 
SH97
 c
 000001100110001000000001000000 11 (4.8 %) 1 (0.8 %) 0.063
 
 
SH95
 c e
 000000000000010000000000010010 3 (1.3 %) 8 (6.4 %) 0.019 
SH84 010111000000000000000000010000 7 (3.1 %) 4 (3.2 %) 1.000
 
 
SH104 010100000110001110110010000111 6 (2.6 %) 4 (3.2 %) 0.746
 
 
SH39 000000000000010100110000000111 6 (2.6 %) 3 (2.4 %) 1.00
 F
 
SH10 000000011100000000000000010000 3 (1.3 %) 4 (3.2 %) 0.247
 
 
SH71 000000000000000000000001000011 3 (1.3 %) 4 (3.2 %) 0.247
 
 
SH92 000001000000000000000001000011 6 (2.6 %) 1 (0.8 %) 0.429
 
 
SH70
 c
 000000000011100101100000101000 2 (0.9 %) 5 (4.0 %) 0.055
 
 
SH17
 c
 000000011000000101100000101000 2 (0.87 %) 4 (3.2 %) 0.190
 
 
SH34 000000011010000101101100000010 3 (1.3 %) 3 (2.4 %) 0.428
 
 
SH41 000000010000010000000000010111 5 (2.2 %) 1 (0.80 %) 0.669
 
 
SH94 001001000110000100110000000000 3 (1.3 %) 3 (2.4 %) 0.428
 
 
SH105 010100000110001000000000010000 5 (2.2 %) 1 (0.8 %) 0.669
 
 
 
a
 Defined by alleles of SNP in the order shown in Table 6. 
b
 Frequency of patients with each haplotype based on the most probable assignment for each individual. 
c
 Seven haplotypes carried forward into multivariable analyses are marked with shading. 
d 
Two-tailed Fishers exact tests were substituted where any categorical frequencies fell below 5. 
e 
Only a single haplotype reached significance in univariate analysis. 
 
Table 5.3: Logistic regression models define gender and haplotypes as predictors of NTM disease. 
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Variable Odds Ratio P-value 95% confidence interval 
Model combining gender and haplotypes (n = 353
 a
, p < 0.0001; R
2
 = 0.05) 
Gender
 b
 0.43 0.001 0.267-0.70 
SH95
 b
 5.62 0.014 1.425-22.13 
SH70 4.90 0.064
 
 0.910-26.36 
Model combining haplotypes (n = 353
 a
, p = 0.0013; R
2
 = 0.04) 
SH97 0.18 0.104 0.023-1.420 
SH95
 b
 5.31 0.015 1.380-20.42 
SH70 4.98 0.058 0.950-26.08 
SH17 3.98 0.114 0.718-22.08 
a 
Excluding samples with genotyping failures. 
b 
Variables achieving significant association with pulmonary NTM disease within the logistic 
regression models.
46 
 
5.4) Discussion  
Exposure to potentially pathogenic mycobacteria from the environment is ubiquitous, so the 
mechanism behind the rare and selective distribution of infection in the population presents an 
apparent paradox. Genetic predisposition seems the most likely influence. Here polymorphisms 
within three genes involved in the inflammatory immune response were investigated. As pulmonary 
NTM disease generally develops during the later years of life (average patient age 60 years (Kim et 
al., 2008)) in individuals without histories of bacterial infection, it is unlikely that factors increasing 
susceptibility reflect a primary immunodeficiency. Hence loss-of function mutations in any of the 
genes of interest would be poor candidate polymorphisms. The SNP investigated in this study are 
likely to have more subtle effects. Here the clearest confounding factor was gender, with 59-95% of 
reported cases being in females (Huang et al., 1998, Kim et al., 2008, Winthrop et al., 2010). 
Gender was included in multivariate analyses here in order to confirm an independent effect from 
the genes under study. 
Of the seven haplotypes meeting the P < 0.20 cut-off in univariate analyses, SH95 was most clearly 
associated with pulmonary NTM disease (Tables 5.2 and 5.3). None of the three SNP displaying 
minor alleles (rs12301635, rs7975295, and rs7314454) in this haplotype (present in P2X7R and 
CAMKK2) were independently associated with disease (i.e.: none met the P < 0.20 exploratory cut-
off). 
 SH70 and SH83 associated weakly with risk and protection (respectively) in univariate analysis 
and shared several SNP alleles. The three alleles (rs10849849, rs1718125 and rs1186055) 
distinguishing these haplotypes lie within P2X7R, and do not explain the associations observed at 
the haplotype level. We also compared SH97 (potentially protective) with the three haplotypes most 
closely linked with risk (SH95, SH70 and SH17). No minor alleles of SH97 were shared with either 
SH95 or SH17, but single minor allele was present in both SH97 and SH70, rs1653609 (P2X7R). 
As SH97 and SH70 are associated with protection and risk respectively, the impact of a minor allele 
at rs1653609 remains unclear. 
These discrepancies between haplotypes and their contained SNP allele associations may be 
explained by linkage disequilibrium between the alleles identified and other as yet unidentified 
alleles. These may be within P2X7R or CAMKK2 regions of the genome or in strong linkage 
disequilibrium with them. Alternatively, these alleles may require a second polymorphic allele in a 
pathway related gene before a contextual loss-of-function phenotype is observed. Further work is 
required to characterise the relationships between these haplotypes and pulmonary NTM disease. 
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While haplotypes displaying associations with disease were observed containing minor alleles 
present in P2X7R and CAMKK2, there was no evidence of a similar relationship for P2X4R alleles. 
No SNP alleles investigated in P2X4R met the exploratory cut-off (P < 0.20) in univariate χ2 
analysis, no haplotypes with significant association to disease contained minor alleles of any SNP 
within P2X4R, and no single allele differences between haplotypes with polarizing effects on 
disease risk were present.  
This exploratory study implicates P2X7R and perhaps CAMKK2 (and their protein products P2X7R 
and CaMKK2) in pathways affecting pulmonary NTM disease, whilst P2X4R was not associated 
with disease protection or risk. Confirmatory studies in additional cohorts are required to confirm 
the results obtained. Future work would investigate P2X7R and CAMKK2, genes in linkage 
disequilibrium with them, and genes encoding products in the same pathways in more depth and in 
larger cohorts.  
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Chapter 6: 
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6) Conclusions and Future Studies 
 
6.1) How do environmental conditions influence exposure to NTM? 
NTM are prevalent in the environment. Although exposure to environmental NTM via aerosolised 
water, dust and/or soil is universal only a few people develop clinical disease. Risk of infection 
from environmental NTM is multifactorial involving host defence mechanisms, pathogen virulence 
and magnitude of exposure (Figure 2) (Mirsaeidi et al., 2014, Johnson and Odell, 2014).   
 
Figure 2: A proposed virulence-exposure-host model for NTM infection (adapted from Mirsaedi et al, 2014). 
Orange arrows represent pathways to infection and disease not demonstrated by Mirsaedi et al. Red arrows 
demonstrate a path to disease possible in our cohort of seemingly immunocompetent individuals possessing 
the IL10 rs1518111 allele associating with disease risk. 
 
6.2) The relevance of bacterial load 
At least 40 species of NTM are associated with lung infections, with most caused by members of 
the Mycobacterium avium complex (MAC), Mycobacterium kansasii, and Mycobacterium 
abscessus (Johnson and Odell, 2014, Daley and Griffith, 2010). Although the infectious dose for 
NTM may vary between species and strains, it is estimated that 10-100 M. bovis organisms are 
enough to cause pulmonary infection (O'Reilly and Daborn, 1995). In mice exposed to 10
2
 and 10
3
 
aerosolised M. abscessus organisms, 10
3
 organisms resulted in pulmonary infection but 10
2
 were 
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insufficient (Ordway et al., 2008). These studies lend credibility to the theory that exposure to high 
environmental pathogen loads is a central component of infection. As of yet, there are no studies 
investigating the bacterial doses required for infection in Mycobacterium avium complex (MAC) 
and Mycobacterium kansasii. 
 
6.3) Previous environmental studies do not address bacterial load 
Previous studies have investigated environmental conditions associated with pathogenic 
mycobacterial presence in drinking water distribution systems (Liu et al., 2012, Dubrou et al., 
2013). However these did not provide absolute abundances of pathogenic species at each point 
sampled, with no distinction made between a sample containing 10 viable pathogens per Litre and 
one containing 10
4
 pathogens per Litre. Future studies could achieve this with the use of sequencing 
methods such as multiplex PCR (see Table 2).  
As a part of this study, a review paper summarising reported links confirmed between 
environmental NTM and pulmonary infection in the literature has been published (Chapter 3) 
(Halstrom et al., 2015). The degree to which pathogen loads in the environment are responsible for 
disease in local residents is a target of future studies. 
 
6.4) The importance of human to human transmission 
Since the publication of our review paper (Halstrom et al., 2015), findings indicating a major role 
for human to human transmission of M. abscessus lung disease have been published (Bryant et al., 
2016). However, it should be noted that M. abscessus is known for its unique, more aggressive 
disease presentation when compared to other NTM species, and that it is classified as a fast-grower 
rather than a slow–grower. It remains to be seen whether human to human transmission is similarly 
important in the species primary responsible for NTM pulmonary disease (M. avium and M. 
kansasii, both being slow-growers).  
 
6.5) The impact of IL10 polymorphisms on disease 
After investigation of seven SNP within IL10, one (rs1518111) demonstrated a significant 
association with incidence of pulmonary NTM disease in our cohort. This consolidates IL10 and 
genes in strong linkage disequilibrium with it as genes of interest for future studies of pulmonary 
NTM disease.   
51 
 
Differences in likelihood of pulmonary NTM disease are observed between ethnicities with the 
highest being observed in Asian/Pacific Islanders in a multi-ethnicity study of NTM disease in the 
USA (Adjemian et al., 2012). Frequency of reported disease was lower in Caucasian, Hispanic and 
African ethnicities respectively (see Figure 4) (Adjemian et al., 2012).  The frequency of SNP 
alleles associating with pulmonary NTM disease was therefore compared between cohorts of 
differing ethnicity where available. These comparisons were made with available online data from 
the 1000 genomes project (Figure 3) and with data generated by our lab where available. MAF for 
rs1518111 varies significantly between ethnic groups. 
 
 
Figure 3: Allele frequencies from the 1000 Genomes project across all available ethnicities for our primary 
SNP of interest, rs1518111 (IL10) (Consortium, 2015). The abbreviations for the 5 super populations are 
AFR: African, AMR: Ad mixed American, EAS: East Asian, EUR: European and SAS: South Asian. The 
abbreviations for each subpopulation within the superpopulations are detailed in Table 8. 
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Table 8: Ethnicity population codes from “1000 genomes”, for reference with Figure 3.  
Super Population  
Code 
Population description Population 
code 
EAS Han Chinese in Bejing, China CHB 
EAS Japanese in Tokyo, Japan JPT 
EAS Southern Han Chinese CHS 
EAS Chinese Dai in Xishuangbanna, China CDX 
EAS Kinh in Ho Chi Minh City, Vietnam KHV 
EUR Utah Residents (CEPH) with Northern and Western Ancestry CEU 
EUR Toscani in Italia TSI 
EUR Finnish in Finland FIN 
EUR British in England and Scotland GBR 
EUR Iberian Population in Spain IBS 
AFR Yoruba in Ibadan, Nigeria YRI 
AFR Luhya in Webuye, Kenya LWK 
AFR Gambian in Western Divisions in the Gambia GWD 
AFR Mende in Sierra Leone MSL 
AFR Esan in Nigeria ESN 
AFR Americans of African Ancestry in SW USA ASW 
AFR African Caribbeans in Barbados ACB 
AMR Mexican Ancestry from Los Angeles USA MXL 
AMR Puerto Ricans from Puerto Rico PUR 
AMR Colombians from Medellin, Colombia CLM 
AMR Peruvians from Lima, Peru PEL 
SAS Gujarati Indian from Houston, Texas GIH 
SAS Punjabi from Lahore, Pakistan PJL 
SAS Bengali from Bangladesh BEB 
SAS Sri Lankan Tamil from the UK STU 
SAS Indian Telugu from the UK ITU 
 
With extensive data on allele frequencies of rs1518111 across so many ethnicities, our first thoughts 
were to use this data in a direct comparison with pulmonary NTM disease incidence between 
ethnicities to assess the extent of the allele’s role in ethnicity related predisposition to disease. 
However, due to unreliable reporting of NTM disease in countries where tuberculosis is endemic 
resulting in a lack of accurate data on disease incidence, this generalised statistical comparison was 
not plausible.  
Frequency of the minor (A) allele for rs1518111 (which was associated with reduced risk of 
pulmonary NTM disease in this project) is lowest in our Caucasian cohort (MAF 0.15), and two-
fold higher in the Indonesian and African cohorts (MAF 0.38 and 0.36 respectively) in data 
collected from our group and assayed with the microarray described herein (Dmello et al., 2017). 
This is consistent with available 1000 Genomes data (Figure 3). If a rough comparison is performed 
based on the findings of Adjemian et al. (Figure 4), there is no consistent parttern between risk due 
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to ethnicity and risk due to carraige of the minor A allele of rs1518111. This suggests a factor other 
than IL10 polymorphism as the cause of varying pulmonary NTM disease susceptibility between 
ethnicities. Nonetheless the association between the minor (A) allele of rs1518111 and disease may 
be the result of biological effect. 
 
 
Figure 4: Period prevalence of pulmonary NTM cases among a sample of U.S. Medicare Part B enrollees 
aged 65 and older from 1997 to 2007 by sex and race/ethnicity (Adjemian et al., 2012). 
 
To determine global significance of the SNP allele in terms of its effect on risk of contracting 
pulmonary NTM disease, studies investigating IL10 polymorphism associating with disease should 
be repeated on cohorts of different ethnicities. More accurate and representative reporting of 
pulmonary NTM disease in communities of different ethnicities will allow practical comparisons 
between ethnicity and genotype risk factors in the future. We note that this is problematic in 
populations with high rates of tuberculosis 
 
6.6) The impact of P2X4R, P2X7R and CAMKK2 polymorphisms on disease 
Unlike the investigation of IL10, no SNP investigated within the P2X4R, P2X7R, CAMKK2 block 
displayed alleles independently associated with pulmonary NTM disease. For this reason,   
haplotype analysis was performed. 
54 
 
One haplotype (SH95) was identified that occurred in 6.4% of the patient cohort and was 
significantly associated with disease. As no individual SNP within the haplotype significantly 
associated with disease, the haplotype may mark untyped SNP in these or adjacent genes. 
Alternatively there may be some interaction which only occurs with this specific combination of 
SNP alleles, increasing risk from pathogenic NTM. A fellow student (Ms Jessica Gaff, Curtin 
University) has documented significant (p < 0.05) differences in the minor allele frequency of 37 of 
the same SNP in the P2X4R, P2X7R and CAMKK2 region between Indonesians, Caucasian 
Australians, and South Africans (Gaff, 2017). For example; the minor allele of P2X7R SNP 
rs10160951 associated with sensory neuropathy in South African HIV patients but was not present 
in Indonesian HIV patients (irrespective of sensory neuropathy) or in any Australian participants, so 
could not be correlated with disease in these ethnicities. Several genotyped alleles (rs11065456, 
rs208294, rs208307, rs12299020, rs504677, rs10160951, rs2230912, rs2668252, rs11608486, 
rs1169719, rs11065502, rs11065503, rs11837114, rs1718120 and rs2686367) were excluded from 
the present analysis as alleles were not in HWE or were monomorphic in our Caucasian cohort, but 
they may be of interest in other ethnicities. 
Studies of P2X7R allele associations with pulmonary and extrapulmonary tuberculosis have 
achieved mixed outcomes dependent on the ethnicity of the patients. For example; in Chinese 
Tibetans the “C” allele of rs656612, “A” allele of rs7958311, and “A” allele of rs208290 were 
associated with increased pulmonary tuberculosis risk (Zhu et al., 2016). The polymorphism 
A1513C (rs3751143) within P2X7R was also a significant risk factor for pulmonary tuberculosis in 
Asians, but not in Caucasians (Alshammari et al., 2016). These findings are not completely 
consistent with those of Ms Jessica Gaff for this SNP (rs3751143) for sensory neuropathy risk, with 
no link found with allele frequency and disease in the ethnicities investigated (including 
Indonesians) (Gaff, 2017). There were however differences in allele frequency observed for 
rs3751143 between Indonesians (0.23), South Africans (0.02) and Australians (0.18).  
The variability of allele frequencies seen between ethnicities in these alleles demonstrates the 
importance of controlling for ethnicity in genotyping studies of this region. Further investigation of 
this gene cluster and polymorphic alleles in adjacent genes is warranted. 
 
6.7) Genes for future study 
Of the genes investigated in this project, IL10 appears to be the most promising, further implicating 
IL10 and other genes involved in inflammatory regulation/response (and possibly other genes in 
close proximity to IL10 on chromosome 1). Based on previous findings, other genes of interest for 
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future investigation of pulmonary NTM disease risk include TNFA and IL28B (identified SNP 
alleles in each of these associating with disease in a Caucasian cohort) (Affandi et al., 2013). Other 
groups have investigated NRAMP1 and found heterozygosity in three different SNP to be associated 
with pulmonary NTM disease, warranting further investigation of this gene (Koh et al., 2005, 
Tanaka et al., 2007). Other genes identified as “of interest” but not yet investigated include IL7, 
ABCA3, and the pulmonary surfactant family of genes (SFTPA/B/C/D). IL7 is a novel choice for 
investigation, as it has not yet been implicated in pulmonary disorders. However, it may be worth 
investigating due to its important central role in the functioning of the innate-like lymphoid cell 
response which is under investigated and may play a key role in inflammation and the clearance of 
bacterial infections of the lung (Spits and Di Santo, 2011). Polymorphisms in ABCA3 and the 
pulmonary surfactant family of genes have been found to affect patient outcome in a range of 
pulmonary conditions, including COPD, Influenza A infection induced severe respiratory 
insufficiency and risk of bronchopulmonary dysplasia, but have not yet been investigated in relation 
to pulmonary NTM disease (Herrera-Ramos et al., 2014, Yang et al., 2014, Zhang et al., 2015). 
To summarise our findings - Genes in which no correlation was found with NTM disease include 
TLR2 and IL4 (Table 9) and BAT1, IL1A, IL2, IL4, IL18, CCL2, VDR, CD14, IL12B, IL28B and 
SLC11A1 typed previously (See table 1) (Affandi et al., 2013). Although we cannot rule out the 
influence of these genes further analyses are a low priority. 
 
Table 9: IL4 and TLR2 SNP investigated were not associated with NTM disease in univariate analyses 
(unpublished data). 
SNP Gene MA 
MAF  
Control 
MAF 
 
NTM 
P-value 
(χ2) 
   (n = 229) (n = 124)  
rs3804099 TLR2 C 38.6% 34.7% 0.14 
rs3804100 TLR2 C 7.0% 6.4% 0.91 
rs5743704 TLR2 A 4.6% 4.8% 0.92 
rs2243250 IL4 T 13.5% 14.1% 0.60 
rs2070874 IL4 T 12.9% 16.1% 0.35 
rs2243282 IL4 A 10.9% 12.1% 0.99 
rs2227284 IL4 R 27.5% 29.4% 0.06 
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6.8) Directions for future work 
Ultimately, it appears many environmental, genetic and physiological factors contribute to an 
individual’s risk of contracting pulmonary NTM disease. In this project we have reviewed the 
evidence linking environmental NTM exposures to disease.  The most common known mode of 
pathogenic NTM transmission leading to infection in the literature is from aerosolisation and 
inhalation of contaminated water, but other sources of transmission (namely aerosolised soil and 
dust) require further investigation. We also highlighted the problems faced when investigating 
environmental factors and have offered suggestions for studies which would shed light on the 
primary sources of transmission from the environment. Namely, the need for studies matching 
patient isolates to environmental sources. We also investigated the associations between disease 
incidence and polymorphic alleles in select genes of interest, finding a relationship between IL10 
polymorphism and disease incidence.  
Future efforts to investigate the risk factors involved in contraction of pulmonary NTM disease 
should centre around immunological pathways crucial to a healthy immune response against the 
bacteria. IL10 was identified as a genetic target of interest from previous immunological studies of 
IL-10 levels in patients of pulmonary NTM disease (Lim et al., 2010) and this relevance has been 
confirmed via significant allele associations for a SNP within IL10. This workflow has proved 
successful in discovering a link with IL10, and may work again for other mechanisms affecting 
disease contraction.  
A current area of interest requiring investigation in pulmonary NTM disease is the role of the 
unconventional innate-like lymphoid cell subsets and the role they play in a successful immune 
response to bacterial infection. These cells include MAIT cells, iNKT cells and γδ T-cells amongst 
others, and should be investigated in patient and control peripheral blood to determine any 
difference in proliferation or activation. Genetic polymorphisms affecting these responses may also 
be informative. Ideally, future immunological and genetics studies would match patients and 
healthy controls for perceived levels of exposure to NTM in the environment (gardening, spa-baths, 
humidity at residence etc.) as well as age and gender matching to eliminate as many confounding 
factors as possible. If any particular mechanism appears to differ significantly between patients and 
controls from these initial screens the genes involved would be targets of significant interest for 
follow up genetic and immunological studies.   
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